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WB 4101 2(N[2,6-dimethoxyphenoxyl])amino-methyl-1,4-
benzodioxane 
vi 
Epi Epinephrine 
NPY Neuropeptide Y 
EDRF Endothelium-derived relaxing factor 
CGRP Calcitonin-gene related peptide 
SP Substance P 
VIP Vasoactive intestinal peptide 
NO Nitric oxide 
SR Sarcoplasmic reticulum 
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GENERAL INTRODUCTION 
Statement of the Problem 
During pregnancy, the blood flow through the uterine 
artery and umbilical vasculature is crucial for the survival 
and growth of the fetus. These two vascular systems are 
potential sites for the action of vasoconstrictors, such as 
norepinephrine (NE), 5-hydroxytryptamine (serotonin, S-HT), 
endothelin-1 as well as others. Norepinephrine, 5-HT and 
endothelin-1 all have been found to be potent constrictors 
of uterine and umbilical vascular beds except for NE on the 
umbilical artery (Dyer, 1970; Ekstrom et al., 1991; Isla and 
Dyer, 1990; Mak et al., 1984; MacLean et al., 1992; Somlyo 
et al., 1965; Zhang and Dyer, 1990a, 1990b; 1991a). However, 
the mechanisms underlying the contractions induced by these 
agents are not fully investigated. Isolated tissues have 
been extensively used for investigating effects due to 
receptor-agonist interaction. Compared with studies in 
whole animals, the use of isolated tissue preparations 
greatly reduce problems associated with the distribution and 
metabolism of agonists. Isolated tissue preparations also 
eliminate many complications such as feedback effects. Our 
laboratory has been studying the constrictor mechanisms in 
the uterine and umbilical vessels. The use of isolated 
uterine and umbilical blood vessels permits us to study the 
mechanisms for vasoconstriction and vasodilation in depth. 
5-Hydroxytryptamine2 (serotonina, S-HTj) receptor-
mediated hydrolysis of phosphoinositide has been documented 
in non-fetal vessels (Doyle et al., 1986; Roth et al., 
1986). Previous study from our laboratory indicated the 
presence of B-HTj receptors in the ovine umbilical artery 
(Zhang and Dyer, 1990b). In study one we examined whether 
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activation of S-HTj receptors induces hydrolysis of 
phosphoinositide in the ovine umbilical artery. 
In a physiological environment, it is possible for 
various vasoconstrictors to be present simultaneously in the 
vicinity of the vascular smooth muscle. The interaction 
between NE and 5-HT has been demonstrated in various vessels 
(Luscher and Vanhoutte, 1988; Meehan et al., 1986; Stupecky 
et al., 1986; van Nueten et al., 1981). The interaction 
between NE and 5-HT on the uterine vascular smooth muscle 
could play a role in regulating uterine blood flow during 
pregnancy. Study two was designed to investigate the 
interaction between NE and 5-HT in the ovine uterine artery. 
Both the ovine uterine artery and umbilical vein contain 
Qfi-adrenoceptors (Zhang and Dyer, 1990a; 1991a) . Since the 
middle of 1980s, it has been clear that the o!i-adrenoceptor 
is heterogenous (Minneman and Esbenshade, 1994). In study 
three, we applied pharmacological tools to characterize the 
subtypes of adrenoceptors in the ovine uterine artery and 
umbilical vein. 
Protein kinase C (PKC) has been suggested to have a 
role in agonist-induced contraction of smooth muscle 
(Rasmussen et al., 1987). Magness et al. (1991) reported the 
presence of PKC in the ovine uterine artery. In study four, 
the role of PKC in contractions induced by NE and 
endothelin-1 on the isolated ovine uterine artery was 
investigated. 
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Dissertation Organization 
This dissertation is presented as a general 
introduction, a review of the literature, four papers 
prepared for publication, a general summary, a list of 
references cited in chapters other than papers, a general 
summary and acknowledgements. 
This dissertation contains the experimental results 
obtained by the author during his graduate study under the 
supervision of his major professor. Dr. Donald C. Dyer. 
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REVIEW OF LITERATURE 
1. Physiology and Pharmacology of the Uterine Vasculature 
1.1. Anatomy of the Uterine Vasculature 
1.1.1. Anatomy of the uterine artery 
In humans and in several laboratory animals (guinea 
pig, rat), the terminal part of the abdominal aorta divides 
into two iliac arteries; each iliac artery divides into an 
external and internal iliac artery. The uterine artery 
originates from the internal iliac artery. In the base of 
the broad ligament, the uterine artery progresses medially 
and divides into the cervicovaginal artery and the ascending 
uterine artery at the level of the supravaginal portion of 
the cervix. The ascending uterine artery provides a major 
branch to the upper portion of the cervix (Meschia, 1983). 
In sheep, the caudal end of the abdominal aorta 
trifurcates into two external iliac arteries and a short 
common internal iliac artery. The common internal iliac 
artery is usually less than 1 cm in length before it divides 
into the left and right internal iliac arteries which are 
also referred to as the main uterine arteries. The main 
uterine artery divides into the larger middle uterine artery 
and smaller dorsal uterine artery. The middle uterine artery 
is comparable to the ascending uterine artery in the human 
and in sheep supplies the major portion of the uterine horn. 
The dorsal uterine artery supplies the lower uterine corpus 
and the cervix (Fuller et al., 1975) (fig. 1). 
The arteries supplying the primate (including the 
human) uterus form a myometrial network (arcuate arteries) 
that encircles the organ. From this network arise the radial 
Fig. 1. Vascular anatomy of the sheep uterine circulation 
(Fuller et al., 1975). 
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arteries that are directed toward the uterine lumen. The 
radial arteries become spiral arteries as they pass into the 
uterine mucosa. Shortly after entering the endometrium the 
spiral arteries give off branches, the basal arteries, which 
ramify along the endometrial-myometrial border. Radial 
arteries supply the inner two-thirds of the uterus, while 
spiral arteries supply the endometrium, decidua, and 
placenta during pregnancy (Meschia, 1983). 
In the ewe, the uterine artery branches within the 
broad ligament to supply blood to the uterine horn. Upon 
reaching the mesometrial border, these branches course 
dorsally and ventrally around the uterine horn (Ghoshal, 
1975). These arteries are referred as circumferential 
arteries and are tortuous or coiled. They course between the 
outer and inner layer of uterine smooth muscle. One or two 
of these uterine arteries approach each cotyledon. The 
vessels divide into five or six trunks and pursue a tortuous 
course in the submucosa before dividing again and entering 
the cotyledon (Reynolds, 1963). 
1.1.2. Innervation of the uterine vasculature 
The uterine vascular bed is richly supplied with nerve 
fibers. The nature of the innervation of the uterine vessels 
and its role in the control of the uterine circulation 
probably varies from one animal species to another, and in 
the same species according to the hormonal status and 
gestational age. Earlier studies in Bell's laboratory 
revealed in detail the innervation of the uterine 
vasculature. In guinea pig, noradrenergic nerve fibers are 
distributed along the main uterine arteries as well as the 
secondary uterine arteries, while cholinergic nerve fibers 
were restricted to the main uterine arteries (Bell, 1968; 
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1971). Investigation of laboratory and domestic animals 
revealed that the main uterine arteries of dog and pig were 
supplied with cholinergic nerve fibers, while rat, cat, 
rabbit and cow were devoid of such innervation (Bell, 1971). 
The human uterine vein is not innervated with cholinergic 
nerves (Amenta et al., 1979). 
Using histochemical, immunohistochemical and 
biochemical techniques, some recent studies have confirmed 
the innervation of uterine arteries by adrenergic nerve 
fibers in rat (Garfield, 1986; Papka and Traurig, 1988), cat 
(Aim et al., 1986), golden hamster (Sorger et al., 1983), 
human (Ekesbo et al., 1991; Zuspan et al., 1981), sheep 
(Massmann et al., 1992; Renegar and Rexroad, 1990), guinea 
pig (Fallgren et al., 1989; Morris et al., 1985) and pig 
(Taneike et al., 1994), and by cholinergic nerve fibers in 
guinea pig (Aim et al., 1988; Thorbet et al., 1977), human 
(Amenta et al., 1979; Ekesbo et al., 1991), sheep (Renegar 
and Rexroad, 1990) and mouse (Moscarini et al., 1982). 
In addition, other neurotransmitters have been found 
to be present in uterine arteries of various species, i.e. 
neuropeptide Y (NPY) in human, rat and guinea pig (Morris et 
al., 1985; Papka and Traurig, 1988; Stjernquist et al., 
1991); vasoactive intestinal peptide (VIP) in human, guinea 
pig, rat, cat, goat, pig and rabbit (Delia et al., 1983; 
Ekesbo et al., 1991; Ottesen et al., 1981; Stjernquist et 
al., 1985); substance P (SP) in human and guinea pig 
(Fallgren et al., 1989; Heinrich et al., 1986); calcitonin 
gene-related peptide (CGRP) in guinea pig (Fallgren et al., 
1989; Mione et al., 1988); dynorphin in guinea pig (Morris 
et al., 1985); somatostatin in human and guinea pig 
(Heinrich et al., 1986; Morris et al., 1985); and 
neurotensin in human (Heinrich et al., 1986). 
In a most recent study, rat uterine blood vessels were 
found to be innervated by 5-HT-like nerve fibers (Amenta et 
al., 1992) . It was suggested that 5-HT released from 
vascular adrenergic nerve endings may contribute to the 
maintenance of local vascular tone (Kawasaki and Takasaki, 
1984) . However, the significance of this observation as to 
how 5-HT may affect/regulate the uterine artery is not 
clear. Also, Toda and coworkers (1994) found the human 
uterine artery to be innervated by vasodilator nerve fibers 
which use nitric oxide as a neurotransmitter. 
The density of the uterine adrenergic nerve fibers 
during pregnancy has been found to be decreased in sheep 
(Sigger et al., 1986), human (Thorbert et al., 1979), dog 
(Ryan et al., 1974), cat (Aim et al. 1986), and guinea pig 
(Owman et al., 1980). The density of innervation of the 
uterine vasculature is also under the influence of 
pregnancy. The number of adrenergic nerve fibers in the 
uterine artery decreased during pregnancy in the guinea pig 
(Bell and Malcolm, 1978; Mione et al., 1990), sheep (Sigger 
et al., 1986) and dog (Ryan et al., 1974). This reduction 
could be mimicked by intrauterine progesterone treatment 
(Bell and Malcolm, 1978). The degeneration of adrenergic 
nerve fibers could result in the withdrawal of normal 
sympathetic vasoconstrictor tone as well as the development 
of hypersensitivity of the uterine vasculature to 
catecholamines. 
1 . 2 .  Physiology of the Uterine Vasculature 
1.2.1. Structural, biochemical and functional changes 
during pregnancy 
The structure of the uterine artery changes markedly 
during pregnancy to accommodate the substantial rise in 
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uterine blood flow. Uterine artery diameter markedly 
increased during pregnancy in human (Annibale et al., 1990; 
Palmer et al., 1992), pig (Guenther et al., 1988) and sheep 
(Fuller et al., 1975). The increase in diameter of the 
uterine artery with pregnancy is not merely the result of 
passive dilation, since wall thickness is unchanged 
(Griendling et al., 1985). This finding suggests that there 
is active growth of the uterine arterial wall. Griendling et 
al. (1985) suggested that this arterial growth is 
accomplished by a 2.5-fold increase in smooth muscle mass. 
Biochemical changes in the uterine artery during pregnancy 
have also been observed. The collagen content of the porcine 
and ovine uterine artery declined progressively throughout 
pregnancy while elastin and RNA remained unchanged 
(Griendling et al., 1985; Guenther et al., 1988). Cytosol 
PKC of uterine artery declined with the advancement of 
gestation of pig whereas PKM (proteolytic product of PKC) 
progressively increased (Farley and Ford, 1992). In sheep, 
uterine arterial PKC activity was higher during the luteal 
phase than in follicular phase and decreased during 
pregnancy (Magness et al., 1991). Estrogen receptor level of 
rat uterine artery increased during pregnancy (Leiberman et 
al., 1993). 
Contraction and relaxation of the uterine artery are 
also affected by pregnancy. The relaxant effect of sodium 
nitroprusside was attenuated in guinea pig uterine artery 
during pregnancy (Weiner et al., 1991) . There was an 
increase in the relaxant response and efficacy to 
acetylcholine of the guinea pig uterine artery during 
pregnancy (Weiner et al., 1989). There was no change in 
potassium-induced contraction of guinea pig uterine artery 
during pregnancy (D'Angelo and Osol, 1993; Fallgren et al., 
1988) . However, potassium-induced vasoconstriction and 
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uptake were decreased in porcine uterine artery during 
pregnancy (Farley and Ford, 1992) . Other alterations related 
to vasoactivity will be discussed in the coming sections. 
Pregnancy is associated with dramatic increases in 
uteroplacental blood flow (Clapp, 1978; Guenther et al., 
1988; Palmer et al., 1992; Rosenfeld, 1977; Thaler et al., 
1990) . In late pregnancy, the uterine arteries carry about 
20% of the maternal cardiac output, with approximately 80% 
of the uterine blood flow going to the placenta. Such a 
large increase is thought to be the result of both an 
accelerated vessel growth and dilation of the vasculature. 
Although the blood vessels can still dilate in response to 
estrogen in late pregnancy, the magnitude of the response is 
decreased, suggesting that the vasculature is already almost 
maximally dilated. 
1.3. Pharmacology of the Uterine Vasculature: Catecholamines 
and 5-Hydroxytryptamine 
1.3.1. Catecholamines 
Catecholamines, such as NE and epinephrine (Epi), are 
either released from sympathetic nerve fibers as 
neurotransmitter or secreted from the adrenal medulla as 
hormones. The uterine vasculature is sensitive to the 
vasoconstrictor action of both Epi and NE. The infusion of 
catecholamines into a pregnant animal reduces uteroplacental 
blood flow (Assali, 1981; Barton et al., 1974; Chestnut et 
al., 1986; Chez et al., 1978; Clark et al., 1990; Rosenfeld 
et al., 1976; Rosenfeld and West, 1977). The reduction of 
uteroplacental blood flow caused by Epi and NE can be 
completely inhibited by blocking a-adrenergic receptors with 
phenoxybenzamine (Egund and Carter, 1980; Greiss, 1972). 
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However, infusion of phenoxybenzamine alone had no effect on 
uterine blood flow (Chez, 1978). 
of-Adrenoceptor agonist-induced uterine 
vasoconstriction is primarily mediated by oii-adrenoceptors 
in the human (Stjernquist and Owman, 1990), sheep (Isla and 
Dyer, 1990), and guinea pig (Fallgren and Edvinsson, 1986). 
By using ligand binding techniques, adrenoceptors have 
been quantitively measured in the pig uterine artery (Farley 
et al., 1984). However, Ribeiro and Macedo (1986) argued 
that both Qti" and Qfj-adrenoceptors are present in the human 
uterine artery. In addition, ofj-adrenoceptors are also 
present in the pig uterine artery (Guenther et al., 1988). 
j8-Adrenergic agonists are weak vasodilators in the 
uterine vascular bed of nonpregnant (Barton et al., 1974; 
Greiss and Gobble, 1967; Resnik et al., 1976) and pregnant 
ewes (Erkkola et al., 1981; Hasaart and de Haan, 1987). The 
vascular response to j8-adrenergic agonists is reduced in 
pregnant animals (Erkkola et al., 1981). Isoproterenol had 
no relaxant effect on the PGF20,-contracted guinea pig 
uterine artery (Fallgre and Edvinsson, 1986). The human 
uterine artery was slightly relaxed by isoproterenol (Gough 
and Dyer, 1971). These results indicate that the uterine 
vasculature is under minor /S-adrenergic control. 
Pregnancy-induced refractoriness of the uterine artery 
to vasoconstrictors is controversial. During pregnancy, 
contractions to catecholamines were reduced in the guinea 
pig uterine artery when compared with arteries from 
nonpregnant status (Weiner et al., 1989; 1991). However, the 
sensitivity of the uterine artery to phenylephrine is 
increased in pregnant as compared to nonpregnant sheep 
(Annibale et al., 1989; D'Angelo and Osol, 1993; Osol and 
Cipolla, 1993). However, pregnancy did not change the 
sensitivity of the uterine arteries of the human (Suresh et 
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al., 1985) and rabbit (Moisey and Tulenko, 1983) to 
catecholamines. 
Infusion of dopamine also reduced uterine blood flow 
in pregnant sheep (Fishburne et al., 1980; Santos et al., 
1992). In vitro studies showed that dopamine was a weak 
vasoconstrictor of the isolated human uterine artery 
(Ekstrom et al. , 1991;, Van Nimwegen and Dyer, 1974) . 
1.3.2. 5-hydroxytryptamine 
5-Hydroxytryptamine is a naturally occurring substance 
that has a wide variety of effects. 5-Hydroxytryptamine 
causes vasoconstriction in both pregnant and nonpregnant 
sheep following direct administration into the uterine 
vasculature (Clark et al., 1980). A sub-vasoconstricting 
concentration of 5-HT potentiated the pressor response to 
angiotensin II in both the pregnant and nonpregnant guinea 
pig (Weiner et al. 1987). Serotonergic agonist-induced 
uterine vasoconstriction was mediated by S-HTj receptors in 
the human (Ribeiro et al., 1991) and sheep (Zhang and Dyer, 
1990). Activation of 5-HT2 receptors increased Ca^* influx in 
ovine uterine artery (Zhang and Dyer, 1991b). 5-
Hydroxytryptamine-induced contraction of the guinea pig 
uterine artery was reduced during pregnancy (Weiner et al., 
1992). The attenuation was endothelium dependent, however, 
neither nitric oxide nor prostacyclin was involved. 
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2. Physiology and Pharmacology of the Umbilical Vessels 
2.1. Anatomy of the Urnbilical Vessels 
2 . 1 . 1 .  Umbilical vein 
The oxygenated fetal blood is carried by numerous 
cotyledonary and intercotyledonary branches distributed on 
the fetal side of the placenta. These branches communicate 
with one another and finally converge to form the umbilical 
vein (Assali et al., 1968) (fig. 2). 
In man and primates, there is only one umbilical vein 
while in the sheep and goat there are two. In either case, 
the umbilical vein (or veins) courses along the umbilical 
arteries in the cord from its insertion in the placenta to 
the umbilical ring. Histologically, the vein possesses a 
muscular coat which is thinner than that of the umbilical 
arteries, but thicker than that of any other vein of the 
fetus. There is an attenuated elastic lamina (Sheppard and 
Bishop, 1973). 
In humans, the single umbilical vein passes through 
the umbilical ring into the abdominal cavity of the fetus 
and runs along the abdominal wall enfolded by peritoneum. In 
the sheep, the two umbilical veins contained in the cord 
enter the abdominal cavity and fuse to form a single 
channel. This vessel runs about 2 to 3 cm before entering 
the liver. 
2.1.2. Umbilical artery 
The umbilical arteries may be considered as two large 
terminal branches of the descending aorta. Fetal blood, rich 
in carbon dioxide, enters the placenta via these arteries. 
Fig. 2. Anatomy of the circulatory system in the fetal lamb 
(Assali et al., 1968). 
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Their cross-sectional diameter is smaller than that of the 
umbilical vein. The wall of the umbilical arteries are 
rather thick and very rich in muscular elements. However, 
unlike muscular arteries elsewhere, they lack elastic lamina 
(Shepard and Bishop, 1973). 
2.1.3. Innervation of the umbilical vessels 
The umbilical vessels are not innervated, at least in 
the human (Fox and Khong, 1990; Reilly and Russell, 1977; 
Spivack, 1943). Hence the umbilical vessels are mainly under 
humoral control. However, some studies indicate that the 
fetal end of the vessels is supplied with nerves (Baljet 
and Drukker, 1982; Kawano and Mori, 1990). Although not 
innervated, the umbilical vessels contain enzymes which 
metabolize catecholamines. Monoamine oxidase (MAO) was found 
to be present in the ovine umbilical blood vessels (Dyer and 
Weber, 1971). No subsequent studies have been done to 
subclassify the subtypes of MAO in the ovine umbilical blood 
vessels. Two subtypes of MAO, MAO-A and MAO-B as well as 
catechol 0-methyl transferase (COMT) all have been found in 
the human umbilical vessels (Caramona, 1983; Precious and 
Lyles, 1988; Saarckoski, 1983). The human umbilical artery 
takes up norepinephrine possibly via an uptakea mechanism 
(Gulati and Sivaramakrishna, 1975). 
2.2. Physiology of the Umbilical Vessels 
The role of the endothelium in modulating the 
activities of the umbilical vessels is controversial. Some 
studies indicate that the human umbilical vessels have no 
relaxant response to those agents believed to release EDRF 
and removal of the endothelium does not alter vascular 
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responses to vasoconstrictors (Monuszko et al., 1990), While 
other studies find that histamine, A23187 and bradykinin but 
not acetylcholine and 5-HT (Chaudhuri et al., 1991; Van de 
Voorde et al., 1987) release EDRF in human umbilical artery 
and veins. A most recent study showed that acetylcholine 
relaxed isolated human umbilical artery via an endothelium-
independent process (Xie and Triggle, 1994). Some 
investigators claimed that prostacyclin rather than nitric 
oxide (NO) is an endothelium-derived relaxing factor (EDRF) 
in the human umbilical artery (Klockenbusch et al., 1992), 
whereas others reported that human umbilical vein 
endothelial cells do release NO in response to a-thrombin, 
bradykinin and ionomycin (Tsukakora et al., 1993). 
Furthermore, infusion of NO synthetase inhibitor N"-nitro-L-
Arginine decreased the ovine umbilical blood flow and 
increased umbilical-placental vascular resistance (Chang et 
al., 1992). 
Responses of the umbilical artery to vasodilators are 
also different from that of the systemic vasculature 
(Renowden et al., 1992). The umbilical artery is less 
sensitive to vasodilators, such as sodium nitroprusside, 
forskolin, atrial natriuretic peptide and adenosine 
(Renowden et al., 1992; White, 1988). Forskolin did not 
affect the agonist (histamine and vasopressin)-induced 
increase in [Ca^^] i in human umbilical vein smooth muscle 
cells (Sharma and Bhalla, 1989). 
Studies using human umbilical artery and vein found 
that endothelial cells of these two vessels contain the 
neuropeptides VIP, SP, CGRP and vasopressin (Cai et al., 
1993). However, their physiological roles are not yet clear. 
In addition, endothelin-1 is present in the human umbilical 
artery and vein (Hemsen et al., 1991; Salamonsen et al., 
1992) . 
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2.3. Pharmacology of the Umbilical Vessels: Catecholamines 
and 5-Hydroxytryptamine 
2 . 3 . 1 .  Catecholamines 
Infusion of oe-adrenergic agonist into the ovine fetus 
did not significantly change the umbilical arterial blood 
flow (Adamson et al., 1989; Clark et al., 1990; Oakes et 
al., 1980; van Huisseling et al., 1991; Yoshimura et al., 
1990), although umbilical vascular resistance increased 
(Adamson et al., 1989; Clark et al., 1990; Irion and Clark, 
1990; Oakes et al., 1980). Paulick et al. (1991) found that 
NE and Epi only increased the umbilical venous pressure, but 
did not change the vascular resistance of the umbilical 
artery. In isolated human and sheep umbilical arteries, NE, 
Epi and phenylephrine were weak constrictors (Dyer, 1970; 
Mak et al., 1984; McGrath et al., 1985; Somlyo et al., 1965; 
Tuncer et al., 1985; Yashikawa and Chiba, 1991). It is 
concluded that there is no significant population of 
functional o!i-adrenoceptors in human umbilical artery 
(McGrath et al., 1985). cxa-Adrenergic agonists did not 
contract isolated human and ovine umbilical arteries 
(McGrath et al., 1985; Tuncer et al. , 1985; Zhang and Dyer, 
1991a) . Q!i-Adrenoceptors but not ofj-adrenoceptors were 
pharmacologically identified in ovine umbilical vein (Zhang 
and Dyer, 1991a). 
a-Adrenoceptor antagonists did not change ovine 
umbilical blood flow (Chez et al., 1978; Edelstone et al., 
1980; Oakes et al., 1980), confirming that the umbilical 
vessels are not under sympathetic control. The (3-
adrenoceptor agonist, isoproterenol also had no effect on 
ovine umbilical vascular resistance (Adamson et al., 1989; 
Herman et al., 1978) and produced a small increase in the 
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umbilical blood flow (Chez et al., 1978). Propranolol 
increased umbilical vascular resistance and decreased 
umbilical blood flow in sheep (Parer, 1983). 
Dopamine did not change the ovine umbilical blood flow 
nor umbilical vascular resistance (Santos et al., 1992). In 
human umbilical artery, receptors have been identified 
(Ferrira de Almeida et al., 1993). 
2.3.1. 5-Hydroxytryptamine 
Infusion of 5-HT reduced umbilical blood flow and 
increased ovine umbilical vascular resistance (Berman et 
al., 1978). 5-Hydroxytryptamine is a strong vasoconstrictor 
of isolated human and ovine umbilical arteries (Altura et 
al., 1972; Dyer, 1970; MacLean et al., 1992; Somlyo et al., 
1965; Yashikawa and Chiba, 1991) and veins (Altura et al., 
1972; Dyer et al., 1972; Mak et al., 1984). However, in the 
perfused isolated human umbilical arte2:Y, 5-HT induced a 
biphasic response, vasodilation followed by a strong 
vasoconstriction (Bjoro and Stray-Pedersen, 1986; Haugen and 
Hovig, 1992). The dilatory response was endothelium-
dependent (Haugen and Hovig, 1992). S-Hydroxytryptaminej 
receptors have been identified with pharmacological tools in 
the ovine umbilical artery (Zhang and Dyer, 1990b) and vein 
(Zhang and Dyer, 1990c). 5-Hydroxytryptamine2 receptors are 
also present in human umbilical artery and high oxygen 
tension revealed 5-HTi-like receptors (MacLean et al., 1989; 
Templeton et al., 1991). 5-Hydroxytryptamine-induced 
vasoconstriction of the human umbilical artery is dependent 
on both extracellular and intracellular calcium (Dogan et 
al., 1991). However, in contrast to ovine uterine artery 
(Isla and Dyer, 1990), Ca^* entry blockers were found more 
effective in inhibiting 5-HT- than K''-induced contraction in 
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the isolated human umbilical artery (Medieros and Colixto, 
1990) . 
3. Vasoconstriction and Signal Transduction Pathways in 
Vascular Smooth Muscle 
3.1. Calcium and Vasoconstriction 
It is well established that an increase in cytosolic 
free calcium initiates contraction of vascular smooth muscle 
(Stull et al., 1991). The rise of intracellular Ca^* level 
leads to the binding of Ga^* to calmodulin (CaM). The 
binding of Ca^* to calmodulin then activates myosin light 
chain kinase (MLCK). Upon activation, MLCK catalyzes 
phosphorylation of serine 19 of the 20,000 dalton myosin 
light chain. When phosphorylated, myosin cross-bridges 
undergo rapid cyclic interactions with actin at the expense 
of ATP hydrolysis, which provides the energy for contraction 
(Kamm and Stull, 1985). 
The Ca^* required to activate the contractile reaction 
in smooth muscle comes either from the extracellular medium 
or from intracellular calcium stores (Bolton, 1979; 
Kuriyama et al., 1982). Extracellular calcium concentration 
is approximately 10,000 times greater than that inside the 
resting smooth muscle cell. Cytoplasmic Ca^^ ranges from 
approximately 100 nM in the resting state to about 600 to 
800 nM in maximally contracting smooth muscle (Somlyo and 
Himpens, 1989; Somlyo and Somlyo, 1992). 
Two different types of membrane channels are involved 
in the influx of extracellular calcium into the cell: 
voltage-operated Ca^*channels (VOCs), which open when the 
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membrane is depolarized and receptor-operated Ca^'^ channels 
(ROCs), which open when agonists react with their membrane 
receptors. 
Voltage-operated Ca^^ channels in vascular smooth 
muscle can be classified into two major types according to 
electrophysiological studies: L-type and T-type. The high 
threshold current (L-type) is activated by a large 
depolarization and is relatively slowly inactivated (Bean et 
al., 1986; Benham et al. , 1987; Ganiteuich and Isenberg, 
1991; Loirand et al., 1986; Smirnov and Aaronson, 1992). 
This current is sensitive to 1,4-dihydropyridine. The L-type 
VOC has been cloned from rat aortic smooth muscle (Koch et 
al,, 1990). A low-threshold (T-type) current that shows 
rapid inactivation has also been described by many of the 
above authors. The predominant Ca^^ current in vascular 
smooth muscle cells is carried through L-type Ca^^ channels 
(Bean, 1991). Because of their higher conductance and slower 
rate of inactivation, L-type VOC probably play a more 
important role in contraction of smooth muscle. 
The observations that NE at certain concentrations can 
activate contractions of smooth muscle without causing a 
change in membrane potential or contract smooth muscle that 
are fully depolarized lead to the suggestion that ROCs exist 
in the plasma membranes of these cells (Bolton, 1979; van 
Breemen et al., 1979). Benham and Tsien (1987) showed that 
ATP directly activated ROCs in arterial smooth muscle cells. 
Receptor-operated Ca^'^ channels are insensitive to 
depolarizing stimuli and to Ca^* channel antagonists. In pig 
aortic microsomes, it was found that ROCs activated by NE 
are G-protein-dependent (Blayneys et al., 1992). The ROCs 
were inhibited by cGMP-dependent protein kinase (Blayney et 
al., 1991). Unlike VOCs, ROCs are still not fully 
characterized because of the lack of specific inhibitors. 
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In normal conditions, contraction in response to 
applied agonists often consists of two phases: an initial 
transient (phasic) component followed by a more sustained 
(tonic) component (Bolton, 1979; Kuriyama et al., 1982). In 
most vascular smooth muscle it appears that release of 
intracellular Ca^* by inositol 1,4,5-trisphosphate 
(Ins(1,4,5) P3) is required for the phasic component since 
contraction can be observed in Ca^^-free-EGTA medium or in 
the presence of Ca^'^ antagonists. Ca^* entry from the 
extracellular fluid is required for the tonic component of 
contraction in most vascular smooth muscle. The role of the 
intracellular source of calcium in response to physiological 
agonists can be demonstrated by stimulation of vascular 
smooth muscle in Ca^^-free medium (Steinsland et al., 1973). 
Further evidence came from the finding that efflux 
increased when loaded vascular smooth muscle was 
stimulated with agonists (van Breemen et al., 1986) . 
Chelators of extracellular Ca^* are widely used to inhibit 
the entry of extracellular Ca^*. The contribution of stored 
intracellular Ca^" has been determined by depleting 
releasible intracellular pools by repeated exposure to 
agonists or to caffeine and determining the residual 
contractile response. Studies have shown that a number of 
physiological agonists, such as NE, angiotensin II, 
vasopressin, histamine and prostaglandins, release Ca^'^ from 
the same intracellular pool (Deth and Casteels, 1977; Deth 
and van Breemen, 1974). The importance of extracellular Ca^"" 
for agonist-induced contractions depends on the particular 
muscle and animal species being used (Minneman, 1988). The 
putative mechanisms for agonist-induced contraction is shown 
in fig. 3. 
The sarcoplasmic reticulum (SR) is the physiological 
intracellular source and sink of activator Ca^^ (Bond et 
Fig. 3. Mechanisms of agonist-induced vasoconstriction 
(Morgan et al. , 1991). CaM, Calmodulin; DAG, diacylglycerol; 
IP3, inositol 1,4,5-trisphosphate; MLC-U, myosin light chain 
unphosphorylated; MLC-P, myosin light chain phosphorlyted; 
PC, phosphatidylcholine; PIP21 phosphatidylinositol 4,5-
bisphosphate; PLC, phospholipase C; PLD, phospholipase D; 
PM, plasma membrane; SR, sarcoplasmic reticulum. Although 
DAG is shown in the cytosol, it actually remains in the 
plasma membrane (Berridge, 1987). 
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al., 1984; Kowarski et al., 1985). The amount of calcium 
stored in the SR could be as high as 15 mM and is 
sufficient for the activation of maximal contraction (Bond 
et al., 1984; lino, 1990). The signal for calcium release 
from SR is transmitted to the SR either by Ca^^ or 
Ins (1,4, 5) P3. The former process is called Ca^^-induced Ca^^ 
release (CICR) , and the latter Ins (1,4, 5) Pj-induced Ca^* 
release (IICR). Inositol 1,4,5-trisphosphate is the 
messenger product of the phosphoinositide cascade (Abdel-
Latif, 1986; Berridge, 1987). These two different kinds of 
calcium release mechanisms were shown to be present in 
vascular smooth muscle (Endo et al., 1990; Hasimoto et al., 
1986) . 
The major intracellular calcium release channels are 
the Ins(1,4,5)P3 receptors located on the sarcoplasmic 
reticulum. Inositol 1,4,5-trisphosphate receptors have been 
purified from bovine aortic smooth muscle (Chadwick et al., 
1990). A considerable amount of Ins(l,4,5)P3 receptor mRNA 
was located in vascular smooth muscle (Furuichi et al., 
1990). The purified Ins(l,4,5)P3 receptor has been 
reconstituted into planar bilayer and shown to be an IICR 
channel (Mayerleitner et al., 1991). The Ins(l,4,5)P3 
receptor is inhibited by heparin, whereas this substance has 
no effect on the CICR (Ehrlich and Watras, 1988; Kobayashi 
et al., 1988). The CICR channel is often referred to as the 
ryanodine receptor, since it has a very high affinity for 
ryanodine (Lai et al., 1988). Ryanodine receptors are also 
present in the sarcoplasmic reticulum of vascular smooth 
muscle, however, the expression of these receptors is 
relatively low (Hakamata et al., 1992). The ryanodine 
receptor has been purified from vascular smooth muscle 
(Herrmann-Frank et al., 1991). This receptor is activated by 
Ca^'^ and caffeine and inhibited by ruthenium red, substances 
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that have no effect on the Ins(l,4,5)P3 receptor (Ehrlich 
and Watras, 1988). The increased [Ca^''] i induced by-
Ins (1,4,5 )P3 also activates its own release through CICR 
(Blatter and Wier, 1992). Recently, cADP ribose, a 
nicotinamide adenine dinucleotide (NAD'^) metabolite, has 
been suggested to be a physiological agonist of the 
ryanodine receptors (Berridge, 1993; Galione, 1993). The 
physiological role of CICR in vasoconstriction is not fully 
understood. 
3.2. Phosphoinositide Cascade and Vasoconstriction 
In many cases, neurotransmitters, hormones, and growth 
factors bind to their corresponding receptors, triggering a 
series of events that lead to activation of phospholipase C 
(PLC) through G-proteins. The hydrolysis of phosphoinositide 
by PLC, which produces two second messengers. Ins(1,4,5)Pj 
and diacylglycerol (DAG), is the major controller of 
subsequent events (Berridge, 1987; Rana and Hokin, 1990). 
Inositol 1,4,5-trisphosphate is released into the cytoplasm 
whereas DAG remains in the membrane. Inositol 1,4,5-
trisphosphate has been shown to release calcium from 
nonmitochrondrial stores (Streb et al., 1983) while DAG 
activates PKC (Nishizuka, 1984). These actions trigger 
cellular responses, such as secretion, smooth muscle 
contraction and growth. 
In animal cells there are three major myo-inositol-
containing phospholipids: phosphatidylinositol (PI), which 
usually accounts for over 90% of the total inositol lipid, 
phosphatidylinositol 4-phosphate (PIP) and 
phosphatidylinositol 4,5-bisphosphate (PIPj) . The 
phosphorylated inositides (PI, PIP, and PIPj) generally 
constitute 1-10% of the total inositol lipids. The amount of 
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PIPj that is available for hydrolysis is only sufficient to 
maintain Ins(1,4,5)P3 production for a few minutes, however, 
this hormone-sensitive PIPj pool is rapidly replenished from 
part of the much larger PI pool by the action of PI and PIP 
kinases (Hokin, 1985). 
3.2.1. Isoforms of phospholipase C 
Three types of PLC have been identified in mammalian 
tissues by direct protein isolation, immunological 
characterization and molecular cloning studies: jS, y, and 6. 
Each type contains more than one subtype. There are three 
PLC-jS (/81, (82 and 183) , two PLC-y (71 and 73) and three PLC-6 
(6i, §2 and 63) subtypes. All three subtypes are single 
polypeptides and have similar catalytic properties. They 
hydrolyze three common phosphoinositides: PI, PIP and PIP2 
with the hydrolysis of PIPj being most sensitive. Taylor et 
al. (1992) have provided evidence that the PLC isozyme 
previously designated a is probably a proteolytic product of 
PLC-61. 
The G-proteins involved in signal transduction are 
heterotrimes composed of diverse ce, jS and 7 subunits 
(Oilman, 1987) . Currently, it is known that Gq and Gi 
subfamilies are the regulators coupled to the PLC pathway 
(Exton, 1994; Hepler and Gilman, 1992; Sternweis and Smrcka, 
1992) . To date, there are two discrete mechanisms by which 
PLC isozymes are activated by receptors. Phospholipase C-/?i.3 
are regulated both by Ga subunits of the Gq class (Gcx q/11, 
Go; 16) and by GJ87 subunits. There is compelling evidence 
that the pertussis toxin-insensitive activation of PLC is 
mediated by the a subunit of Gq. All PLC-j8 isozymes are 
activated by Gaq, but PLC-jSi and PLC-jSj are more responsive. 
The pertussis toxin-sensitive activation of PLC is mediated 
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by the /Sy subunit of Gi, to which PLC-jSj is most sensitive 
(Cockcraft and Thomas, 1992; Exton, 1994; Liscovitch and 
Cantley, 1994). Phospholipase C-y isozymes are regulated by 
tyrosine kinases (Cockcraft and Thomas, 1992; Liscovitch and 
Cantley, 1994). The mechanism of PLC-6 activation has not 
been identified. It was suggested that the regulation of 
PLC-61 is through changes in cytosolic Ca^^ (Exton, 1994). 
3.2.2. Formation of Ins(1,4,5)P3 and its metabolism 
Inositol 1,4,5-trisphosphate is formed from the 
hydrolysis of the phosphodiester bond linking the 
phosphorylated inositol unit to the acetylated glycerol 
moiety by phospholipase C. At the same time, DAG is also 
generated by the action of PLC. The metabolism of 
Ins(1,4,5)P3 is a more complex process and leads to increase 
in the levels of a variety of inositol phosphate isoforms. 
There are two routes for catabolism of Ins(1,4,5)P3: 1) 
dephosphorylation and 2) phosphorylation followed by 
dephosphorylation. In the first route, 1) Ins(l,4,5)P3 is 
converted to Ins(1,4)P2 by inositol polyphosphate 5-
phosphatase; 2) Ins(l,4)P2 is hydrolyzed to Ins(4)P; and 3) 
Ins(4)P is dephosphorylated to inositol by inositol 
monophosphatase. In the second route, 1) Ins(l,4,5)P3 is 
first phosphorylated to Ins (1,3,4,5)P4; 2) Ins(1,3,4,5)P4 is 
then dephosphorylated to Ins(1,3,4)P3; 3) Ins(l,3,4)P3 may 
then be converted to either Ins(l,3)P2 or Ins(3,4)Pj by 
inositol polyphosphate 4-phosphatase and inositol 
polyphosphate 1-phosphatase; 4) Ins(l,3)P2 and Ins(3,4)P2 
are hydrolyzed to Ins(l)P and Ins(3)P by inositol 
polyphosphate 3-phosphatase and inositol polyphosphate 4-
phosphatase, respectively; and 5) both Ins(l)P and Ins(3)P 
are dephosphorylated to inositol by inositol 
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monophosphatase. 
3.2.3. Phosphoinositide hydrolysis in vascular smooth 
muscle 
Investigation of the phosphoinositide pathway and its 
regulation in vascular smooth muscle has established the 
molecular basis of vasoconstriction. Membrane receptors, 
such as those for oii-adrenergic agonists, endothelin-1 and 
5-hydroxytryptamine, are coupled to phospholipase C via G-
proteins. 
Phospholipase C-Sj (Kato et al., 1992), PLC-a 
(Griendling et al., 1991) and PLC-7I (Inui et al., 1992) 
have been identified in vascular smooth muscle. The quantity 
of PLC isozymes has been investigated in rat aorta (Rhee et 
al., 1991). Phospholipase C-jS^ exists in low quantities in 
rat aorta (10 ng/mg protein), while PLC-y^ and PLC-S^ are 
relatively rich in the same tissue (120 ng/mg protein each). 
The existence of PLC-a is doubtful since a recent study 
indicated that PLC-a is actually a proteolytic fragment of 
PLC-61 (Taylor et al., 1992). 
Receptor-mediated hydrolysis of phosphoinositide in 
vascular smooth muscle has been well documented, i.e., a^-
adrenoceptors for a-adrenergic agonists (Chiu et al., 1987; 
Fox et al., 1985; Rapoport, 1987), B-HTj receptors for 
serotonergic agonists (Doyle et al., 1986; Roth et al., 
1986), ETA receptors for endothelin (Eguchi et al., 1992), 
ATi receptors for angiotensin II (Ko et al., 1992) and Vi 
receptors for vasopressin (Plevin et al., 1992a). Usually, 
the receptor-mediated hydrolysis of phosphoinositide 
correlates well with the release of Ca^* from intracellular 
stores (Chiu et al., 1987; Pijuan et al., 1993) or 
vasoconstriction (Gu et al., 1991; Pjiuan et al., 1993; Roth 
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et al., 1986), suggesting a link between these two 
phenomena. 
3.2.4. Inositol 1,4,5-trisphosphate and 
vasoconstriction 
The discovery that Ins(1,4,5)P3, the product of PLC-
mediated hydrolysis of PIP2, functions as the second 
messenger for Ca^'' release from endoplasmic reticulum 
constitutes a major breakthrough in the quest to elucidate 
excitation-function coupling (Berridge, 1987). The 
concentration of Ins(1,4,5)P3 in resting cells is about 0.1 
/xM and increases to 1-2 [xM during agonist stimulation 
(Tarver et al., 1987). Inositol 1,4,5-trisphosphate has been 
shown to mobilize Ca^* from the sarcoplasmic reticulum of 
vascular smooth muscle (Hashimoto et al., 1986; Somlyo et 
al., 1985; Suematsu et al., 1984; Yamamoto and van Breemen, 
1985). Furthermore, light activation of caged Ins(1,4,5)P3 
showed that it rapidly released sarcoplasmic reticulum Ca^^ 
at submicromolar concentrations (Walker et al., 1987). In 
many of these cases the release of Ca^* by Ins ( 1,4,5)P3 was 
found to initiate contraction (Hashimoto et al., 1986; 
Somlyo et al., 1985). The role of Ins(l,4,5)P3 in 
vasoconstriction was also discussed in the section 3.1.. 
3.2.5. Isoforms of PKC 
Protein kinase C covers a family of serine- and 
threonine-specific protein kinases. Based on their structure 
and enzymatic properties, PKC isozymes have been classified 
into three groups: 1) the Ca^""-dependent or conventional 
PKCs (cPKCs) ; 2) the Ca^'^-independent or novel PKCs (nPKCs) ; 
and 3) the atypic PKCs (aPKCs) . The PKC isoforms a, /Si, jSj/ 
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and y define cPKC group, the isoforms 6, e, rj and d belong 
to the nPKC group, and the isoforms f and X are two members 
of the aPKC group (Liscovitch and Cantley, 1994; Nishizuka, 
1992) . The cPKC enzymes are activated by Ca^'^, 
phosphatidylserine, and DAG or phorbol esters. The nPKC 
enzymes do not require Ca^^ and are activated by 
phosphatidylserine and DAG or phorbol esters. The aPKC are 
dependent on phosphatidylserine but are not affected by DAG, 
phorbol esters, or Ca^^ (Nishizuka, 1992) . 
3.2.6. Sources of DAG 
The triggers for the activation of the PKC signal 
transduction pathway, is the production of DAG. In response 
to agonists, the formation of DAG is usually biphasic: an 
early transient phase followed by a late sustained phase 
(Griendling et al., 1986; Sunako et al., 1989). The early 
phase parallels the increase in Ins(1,4,5)P3. It is 
suggested that the early transient phase of formation of DAG 
results from the hydrolysis of PIP2 and the late sustained 
phase is due to hydrolysis of phosphatidylcholine (PC) 
(Nishizuka, 1992). Diacyglycerol may be directly produced 
from PC by a PLC (Billah and Anthes, 1990; Exton, 1990; 
Loffelholz, 1989). Alternately, DAG may be produced 
indirectly via phospholipase D (PLD), yielding phosphatidic 
acid (Billah and Anthes, 1990; Exton, 1990; Loffelhalz, 
1989; Thompson et al., 1991), which is then dephosphorylated 
by phosphatidic acid phosphohydrolase (Briendly, 1984). The 
activating effect of DAG on PKC can be mimicked by tumor-
promoting phorbol esters in vitro (Castagna et al., 1982), 
which have become useful tools for studying the roles of 
PKC. 
Agonist-induced activation of PLD or stimulation of 
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hydrolysis of PC in vascular smooth muscle have been well 
documented. These agonists include: 1) NE (Gu et al., 1992; 
Jones et al,, 1993; Nally et al., 1992, Rapoport and 
Campbell, 1991); 2) endothelin (Liu et al., 1992); 3) 
angiotensin II (Lassegue et al. 1993); 4) vasopressin 
(Plevin et al., 1992b; Thibonnier et al., 1991; Welsh et 
al., 1990) and 5) ATP (Nally et al., 1992). 
3.2.7. Protein kinase C and vasoconstriction 
Studies of vascular smooth muscle revealed that phorbol 
esters initiate a slow but long-lasting contraction (Forder 
et al., 1985; Jinag and Morgan, 1987; Savineau et al., 
1991). The calcium requirement of phorbol ester-induced 
vasoconstriction is controversial. An increase in force may 
occur without a change in [Ca^*] ^ (Chatterjee and Tejada, 
1986; Nishimura et al., 1990; Ruzycky and Morgan, 1989; 
Satoh et al., 1987) or be dependent on extracellular Ca^^ 
(Danthuluri and Deth, 1984; Gleason and Flaim, 1986; 
Sawamura et al., 1987). Phorbol esters have been shown to 
contract Ca^'^-depleted vascular smooth muscle (Itoh and 
Lederis, 1987). 
Protein kinase C-a and -jS isozymes of the cPKC group 
have been identified in vascular smooth muscle (Assender et 
al., 1994; Inoguchi et al., 1992; Singer et al., 1992) as 
well as in uterine smooth muscle (Karibe et al., 1991). 
Protein kinase C-e and -f isozymes are also expressed in 
vascular smooth muscle (Dixon et al., 1994; Khalil et al., 
1992) . It was suggested that Ca^*-independent 
vasoconstriction is associated with activation of PKC-e 
(Khalil et al., 1992). 
In contrast to the wealth of information accumulated 
on the activation of this signaling pathway and the 
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structures of the components within it, there is a dearth of 
information on physiological substrates for PKC and in 
particular those whose phosphorylation has a defined effect. 
The mechanism of action of PKC on smooth muscle 
remains to be clarified. The contractile response could 
result from direct or indirect effects of PKC at one or more 
steps in the excitation-contraction coupling pathway. 
Phorbol esters could modulate VOCs in smooth muscle (Fish et 
al., 1988; Galizzi et al. , 1987; Schuhmann and Groschner, 
1994). Activation of PKC by phorbol ester has been shown to 
phosphorylate myosin light chain (Singer, 1990; Sato et al., 
1992), MLCK (Nishikawa et al., 1985;) , desmin (Barany et 
al., 1992), caldesmon (Adam et al., 1989; Barany et al., 
1992), and calponin (Winder and Walsh, 1990). It was 
suggested that the contractile effect initiated by PKC 
activators, such as phorbol esters, is not due to 
phosphorylation of myosin light chain by PKC (Inagaki et 
al., 1987). The physiological importance of phosphorylation 
of these proteins by PKC is not clear. Recently, it was 
reported that the activity of myosin light chain phosphatase 
was inhibited by PKC, and this inhibition is suggested to 
play an important role in Ca^*-independent vasoconstriction 
(Itoh et al., 1993). 
The effects of activation of PKC on agonist-induced 
vasoconstriction is complex. Both augmentation (Bendhack et 
al,, 1988; Nally et al., 1992; Sheridan et al., 1991; Shima 
and Consigny, 1989) and attenuation (Danthuluri and Deth, 
1984; Roth et al., 1986; Satoh et al., 1987; Shima and 
Blaustein, 1992; Villalobos-Molina et al., 1990) have been 
reported. 
Activation of PKC by phorbol esters has been reported 
to have the following diverse actions on signal transduction 
pathways in vascular smooth muscle: 1) attenuation of 
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agonist-induced increase in intracellular Ca^* (Aiyar et 
al., 1987; Berta et al. , 1988; Brock et al., 1985; Caramelo 
et al., 1988; Satoh et al., 1987); 2) inhibition of agonist-
induced phosphoinositide hydrolysis (Araki et al., 1989; 
Bazan et al., 1993; Chardonnens et al., 1990; Cotecchia et 
al., 1985; Go et al., 1988; Griendling et al., 1986; 
McMillan et al., 1986; Pfeilschifter et al., 1989; Reynolds 
et al., 1989; Roth et al., 1986; Vittet et al., 1986); 3) 
increased release of arachidonic acid (Reynolds et al., 
1989); 4) decreased generation of cGMP (Hirata, 1988; Kawabe 
et al., 1992); and 5) enhanced formation of cAMP (Kubalak 
and Webb, 1993; Nabika et al., 1985; Phaneuf et al., 1988). 
However, down-regulation of PKC was shown to cause the 
following: 1) increased agonist-induced phosphoinositide 
hydrolysis (Pfeilschifter et al., 1989); 2) enhanced cGMP 
accumulation (Kawabe et al., 1992); 3) inhibited activation 
of PLD by PKC (Konishi et al., 1991); and 4) enhanced 
agonist-induced Ca^" mobilization (Pfeilschifter et al., 
1989; Stassen et al., 1989). 
It is generally agreed that myosin light chain 
phosphorylation plays an important role in initiating smooth 
muscle contraction (Kamm and Stull, 1985). However, it is 
also evident that myosin light chain phosphorylation is not 
necessary for maintaining isometric force in intact vascular 
smooth muscle, since intracellular levels of free Ca^^ 
decline toward basal level during the maintenance of tone 
(Morgan and Morgan, 1984). Therefore, additional regulatory 
mechanisms for maintaining contraction must be sensitive to 
lower concentration of intracellular Ca^*. 
Studies have shown that force can be developed in the 
complete absence of increases in myosin light chain 
phosphorylation (Chatterjee and Tajeda, 1986; Singer and 
Baker, 1987) , that the crossbridge cycling rate can be 
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regulated independent of changes in myosin light chain 
phosphorylation (Moreland and Moreland, 1987). Some evidence 
suggests that PKC can, apparently, directly initiate the 
development of force supported by a specific population of 
crossbridges characterized by unphosphorylated myosin light 
chain and low cycling rates (Fulginiti et al., 1994). 
Rasmussen (1987) proposed that PKC is responsible for the 
maintenance of tonic force. Later, it was hypothesized that 
these two regulatory systems act in parallel in smooth 
muscle to regulate contraction (Moreland et al., 1991; 
Morgan et al., 1988). One of these is the Ca^^-dependent 
myosin phosphorylation-dephosphorylation system responsible 
for the rapid development of force and the second is a 
hypothesized Ca^'^-dependent system responsible for slow 
development of force as well as the maintenance of 
previously developed force. This second system has a higher 
Ca^* sensitivity than that for myosin light chain 
phosphorylation (i.e. functioning at a lower [Ca]i) and may 
be activated by PKC. The total force maintained by smooth 
muscle is the result of these two regulatory systems acting 
in concert. 
The sensitivity of the regulatory/contractile 
apparatus to Ca^^ can be increased by agonists (Kitazawa et 
al., 1989; Nishimura et al., 1990). The amount of force 
developed at a given [Ca^^] i is significantly greater during 
excitation by an agonist than during depolarization with 
high K^ (Bradley and Morgan, 1987; Himpens et al., 1990; 
Himpens and Casteels, 1987; Rembold and Murphy, 1988). The 
Ca^^-sensitizing action of agonists is mediated by G-
proteins, as it can be mimicked by GTPyS and inhibited by 
GDBjSS (Kitazawa et al. , 1989; Nishimura et al. , 1988). Some 
studies have showed that phorbol esters increased the Ca^^ 
sensitivity of the contractile apparatus (Brozovich et al. 
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1990; Nishimura et al., 1990). 
4. Heterogeneity of ofi-Adrenoceptors 
4.1. Adrenoceptor Subtypes 
Catecholamines such as NE and Epi, are produced in 
and released from nerve terminals and the adrenal chromaffin 
tissue to produce a wide range of effects by activating 
adrenoceptors. Adrenoceptors were initially subclassified 
into 01 and j8 subtypes on the basis of the rank orders of 
potency of a series of structurally related catecholamines 
(Ahlquist, 1948) . Later both jS- and a-adrenoceptors were 
subdivided into jSj,- and 182-adrenoceptors (Lands et al., 
1967) and a^- and Q!2-adrenoceptors (Langer, 1974) . The jS-
adrenoceptors were divided into two classes, jSi- and jSj-, 
based on the relative potencies of isoproterenol, Epi and NE 
(Lands et al, 1967) . -Adrenoceptors demonstrate 
approximately equal affinity for Epi and NE, whereas Pz~ 
adrenoceptors recognize Epi with higher affinity than NE. 
/?!-Adrenoceptors were found predominantly in heart, while 
182-adrenoceptors were found predominantly in smooth muscle. 
Langer (1974) proposed that cXi-adrenoceptors were 
postsynaptic a-adrenoceptors that mediate effector organ 
response, while a2~s<^^snoceptors were presynaptic a-
adrenoceptors that regulated neurotransmitter release. 
However, the discovery of postsynaptic 012-adrenoceptors in 
vascular smooth muscle and platelets (Timmermans and van 
Zwieten, 1981) made it necessary to refine the 
subclassification of a-adrenoceptor subtypes. At present, 
the designations of and a2"^<i^®rioceptors are based 
exclusively on the selectivities of agonists and antagonists 
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for their respective subtypes (Starke, 1981). 
Adrenoceptors, both a and /?, appear to belong to a 
large superfamily of membrane receptors that transmit 
information into the interior of cells through coupling to 
G-proteins (Gilman, 1987/ Lefkowitz and Caron, 1988). 
However, the signaling mechanisms of the a- and /?-
adrenoceptor classes are distinct. /8-Adrenoceptors are 
linked to the activation of adenylate cyclase resulting in 
the generation of the second messenger cAMP. This is true 
for all /?-adrenoceptor types (Bylund, 1992; Lefkowitz et 
al., 1983) . Agonist binding to adrenoceptors leads to the 
activation of PLC and alteration in the intracellular 
calcium concentration (Minneman, 1988) . cxa"Adrenoceptors 
appear to be linked to adenylate cyclase but in an 
inhibitory fashion (Jakobs et al., 1976). a2"Adrenoceptors 
also mediate Ca^'' influx through a pertussis toxin-sensitive 
G protein (Ruffalo et al., 1991). 
Q!i-Adrenoceptors play a dominant role in the control of 
blood pressure, nasal congestion, prostate function, and 
other processes (Minneman, 1988). As such, the number of 
adrenoceptors and the drug specificities of each subtypes 
are of particular therapeutic interest. Therefore, the 
foregoing brief review will focused on q!I-adrenoceptor 
subtypes. 
4.2. aAdrenoceptor Heterogeneity 
Q!i-Adrenoceptors are generally defined as receptors 
which are potently blocked by the competitive antagonists 
phentolamine and prazosin, and irreversibly blocked by the 
alkylating agent phenoxybenzamine, and selectively 
stimulated by the agonists phenylephrine and methoxamine. 
Increasing evidence suggests that cei-adrenoceptors are 
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not homogenous. In the late 1980s, the development of more 
selective drugs and the use of molecular biology techniques 
has provided confirmation of the presence of multiple 
subtypes (Bylund, 1992). The first definitive classification 
of (Xi-adrenoceptor subtypes, established by use of 
radioligand binding, was proposed by Morrow and Creese 
(1986) based on the ability of certain antagonists such as 
WB4101 and phentolamine to discriminate between high and low 
affinity binding sites in rat cerebral cortex. Morrow and 
Creese (1986) designated a^-adrenoceptors with subnanomolar 
affinity for WB4101 as and the ofi-adrenoceptors with 
lower affinity as OIQ. Further characterization with the 
alkylating agent chloroethylclonidine (CEC) was carried by 
Johnson and Minneman (1987). They demonstrated that CEC 
could inactivate only approximately 50% of the 
adrenoceptors in the rat cerebral cortex and could not 
inactivate any cXi-adrenoceptors in rat hippocampus despite 
the fact that all of the cXi-adrenoceptors in both brain 
regions were sensitive to alkylation by phenoxybenzamine. 
Thus it appeared that CEC could discriminate between 
adrenoceptor subtypes and that these subtypes had a 
differential distribution within different regions of the 
brain. Further studies showed that CEC could inactivate 
nearly all of the q!I-adrenoceptors in rat liver and spleen 
but very few of the adrenoceptors in rat vas deferens 
(Han et al., 1987). Those oii-adrenoceptors with low affinity 
sites for WB4101, which are sensitive to CEC , were 
designated cXxb, and those receptors with high affinity for 
WB 4101 were called q!IA (Minneman, 1988) . These findings 
supported the proposed subdivision of adrenoceptors by 
Morrow and Creese (1986). 
Substantial evidence suggests that adrenoceptors 
have a 20- to 100-fold higher affinity than do the cXib" 
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adrenoceptors for the competitive antagonists 5-methyl-
urapidil (Gross et al., 1989; Hanft et al., 1989), (+)-
niguldipine (Boer et al., 1989), WB4101 (Morrow and Creese, 
1986) and benoxathian (Han et al., 1987b). q!ib-Adrenoceptors 
are highly sensitive to inactivation by the site-directed 
alkylating agent CEC. Chloroethylclonidine binds equally 
well to both ttiA" and qTib-adrenoceptors, but it does not 
inactivate the subtype (Han et al., 1987a; Johnson and 
Minneman, 1987) . 
In 1986, there was another attempt to classify cXi-
adrenoceptors. Prazosin is generally accepted as a potent 
and highly selective antagonist of a-adrenoceptors. When the 
receptor dissociation constants for prazosin against a 
variety of oii-adrenoceptor-mediated responses are examined, 
there is a nearly a 100-fold range in the observed 
antagonist affinity (Flavahan and Vanhoutte, 1986). Based on 
prazosin's variable antagonism of functional response, 
Flavahan and Vanhoutte (1986) proposed an, (low affinity 
for prazosin) and am (high affinity for prazosin) subtypes. 
Later, Muramatsu and coworkers (1990a) further extended this 
subdivision to three subtypes: an,, a^a and am (non-an, or 
a^), based on their antagonist affinity and susceptibility 
to CEC in functional studies. However, this proposal was 
mainly based on the data obtained from blood vessels and has 
not been confirmed with binding studies. 
4.3. Molecular Biology of oi^-Adrenoceptor Subtypes 
Recently, molecular cloning techniques have identified 
significant heterogeneity within the a^-adrenoceptor family. 
Three a^-adrenoceptor cDNA clones have been isolated, but 
their relationship to the pharmacologically defined a^^- and 
aiB-adrenoceptor subtypes remains controversial. 
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The first q!I-adrenoceptor cDNA clone was isolated from 
a hamster smooth muscle DDT1-MF2 cell library (Cotecchia et 
al., 1988) . Northern analysis showed the mRNA for this clone 
had a tissue distribution similar to that predicted for the 
aiiB - adrenoceptors. This clone encoded a protein of 515 amino 
acid residues. 
An additional cDNA that encoded a 466-residue 
polypeptide was isolated from a bovine brain library 
(Schwinn et al., 1990). Expression of this cDNA resulted in 
a novel subtype with a unique drug specificity that had a 
relatively high affinity for ai^-selective drugs but was 
sensitive to inactivation by CEC. The a^-adrenoceptor 
encoded by this clone was designated (Schwinn et al., 
1990). Initially, mRNA for adrenoceptor was shown to 
have an extremely restricted distribution and was found in 
detectable quantities in only human hippocampus and rabbit 
liver (Schwinn et al., 1990). However, a most recent study 
indicated that aic'^^i^sJ^oceptor mRNA predominates in many 
human tissues, such as liver, heart, cerebellum, and 
cerebral cortex (Price et al., 1994). 
Two other cDNA clones, with sequences differing by 
only two codons, were isolated independently from rat brain 
libraries (Lomasney et al., 1991; Perez et al., 1991) and 
have been designated as and aip-adrenoceptor subtypes, 
respectively. Stringent pharmacological analysis (Perez et 
al., 1991; Schwinn and Lomasney, 1992) suggested that these 
two clones were identical and that both express proteins 
with primarily cXIB-subtype pharmacology. This clone has thus 
been suggested to be designated as the subtype (Schwinn 
and Lomasney, 1992) 
However, questions have been raised regarding whether 
the cloned ofift/D'^drenoceptor actually represents the true 
pharmacologically defined subtype or, a fourth am" 
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adrenoceptor subtype (Perez et al., 1992). Until this issue 
is resolved, it has been suggested that the cloned cVIA-
adrenoceptor be referred to as the oi-^p,/o subtype (Schwinn and 
Lomasney, 1992). 
4.4. Signal Transduction Mechanisms 
In most cells, the primary functional consequence of 
0!i-adrenoceptor activation is an increase in intracellular 
Ca^". This increase appears to result from the release of 
Ca^* from intracellular stores and/or the influx of 
extracellular Ca^* into the cells. Minneman (1988) initially 
proposed on the basis of functional studies that cyi^-
adrenoceptors were linked to the influx of extracellular 
Ca^'' and otiB-adrenoceptors were coupled to PLC and release of 
intracellular Ca^^. However, the signaling mechanisms for q!I-
adrenoceptor subtypes are more complex than they were 
originally proposed. Investigators now generally agree that 
activation of otia-adrenoceptors increases the formation of 
DAG and Ins (1,4, 5) P3 and that Ins (1,4, 5) P3 mobilize Ca^* from 
intracellular stores. The signaling mechanism for activation 
by the q!IA subtype, however, is less clear. Despite the 
evidence for influx of extracellular Ca^^ through voltage-
operated channels (Han et al., 1987b; Han et al., 1990a; 
Minneman, 1988; Suzuki et al., 1990a; Tsujimoto et al. 
1989) , ofiA-adrenoceptor also increase inositol phosphate 
formation (Cohen and Almazan, 1993; Esbenshade et al., 1993; 
Han et al., 1990b; Michel et al., 1993; Wilson and Minneman, 
1990) . In addition, oiiB-adrenoceptors can activate Ca^^ 
influx (Esbenshade et al., 1994; Han et al., 1992; Klijn et 
al., 1991). Furthermore, all three cXi-adrenoceptor subtypes 
have been shown to activate PLC via Ga^ and (Wu et al., 
1992) . -Adrenoceptors have also been shown to activate 
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phospholipase Aj (Perez et al., 1993) and D (Gu et al., 
1992; Llahi and Fain, 1992). The above evidence indicates 
that Q!i-adrenoceptor subtypes may be coupled to multiple 
signaling mechanisms. 
4.5. a ^-Adrenoceptor Subtypes in Vascular Smooth Muscle 
Extensive studies have been done on vascular smooth 
muscle to characterize cXi-adrenoceptor subtypes. Table 1 
shows an incomplete summary of ofi-adrenoceptor subtypes in 
vascular smooth muscle from functional studies. The 
observations in table 1 suggest that the distribution of the 
subtypes of ofi-adrenoceptors is species- and tissue-
dependent. However, current studies with phaarmacological 
tools also cause confusion. For example, in rat aorta, some 
authors claimed that only the cVIB subtype is present (Han et 
al., 1990a), while other investigators found the presence 
of both cXiA and q!ib subtypes (Piascik et al., 1991) . 
Furthermore, and cxiatypic (non-aia) subtypes have also been 
found in this vessel (Oriowo and Ruffolo, 1992). 
Activation of cXi-adrenoceptors has been reported to 
increase the influx of extracellular calcium and release of 
calcium from intracellular stores (Awad et al., 1983; Deth 
and Lynch, 1981). The rapid phasic contraction caused by 
norepinephrine are mainly caused by Ca^^ release from 
internal stores, whereas slow tonic contractions requires 
Ca^* influx from the extracellular space (Deth and van 
Breemen, 1974, Karaki et al., 1979). Suzuki et al. (1990a) 
observed that Q;iA"^d^®^oceptors caused a tonic response 
which was predominantly dependent on the influx of 
extracellular Ca^^, whereas aiB"^d^6iioceptors stimulated PI 
hydrolysis/intracellular Ca^^ mobilization and caused a 
phasic response in rabbit aorta. This finding was in 
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Table 1. Subtypes of -Adrenoceptor in Vascular Smooth Muscle 
Tissue Subtype(s) Reference 
Rat aorta 
Rat aorta 
Rat aorta 
Rat aorta 
Rat aorta 
Rat renal artery 
Rat mesenteric 
artery 
Rat portal vein 
Rat portal vein 
Rat vena cava 
Rabbit aorta 
Rabbit aorta 
Rabbit aorta 
Rabbit aorta 
Rabbit iliac 
artery 
Canine aorta 
Canine aorta 
Canine lingual 
artery 
Guinea pig aorta 
Monkey lingual 
artery 
®1A '^latypic 
^lA ^latypic 
a IB 
OflB 
OflA + Q!IB 
O'lA 
Q!IA + OilB 
0!IA + (XlB 
a lA 
®1B 
o^iA + Q!IB 
"lA + Q!IB 
(X lA 
®1A ®latypic 
OilA + "iB 
a IB 
®1A ®latypic 
®1A 
®latypic 
"lA + "iB 
Aboud et al., 1993 
Oriowo and Ruffolo, 
1992 
Han et al., 1990a 
Oriowo and Bevan, 
1990 
Piascik et al. 1991 
Han et al., 1990a 
Han et al., 1990a 
Han et al., 1990a 
Schwietert et al., 
1991a 
Sayet et al., 1993 
Suzuki et al., 1990a 
Takayanagi et al., 
1991 
Torres-Marquez et 
al., 1991 
Oriowo and Ruffolo, 
1992 
Takayanagi et al., 
1991 
Hoo et al., 1994 
Oriowo and Ruffolo, 
1992 
Skrbic and Chiba, 
1992 
Oriowo and Ruffolo, 
1992 
Skrbic and Chiba, 
1992 
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agreement with the scheme for subclassifying ai-
adrenoceptors proposed by Minneman (1988). However, several 
other lines of evidence questioned the scheme: 1) cXIB-
Adrenoceptors in rat vena cava was found to be linked to Ca^'^ 
influx (Sayet et al., 1993); 2) Rat portal vein mainly 
contains the ofiA-adrenoceptor subtype and both the phasic and 
tonic responses are mediated by the subtype (Schwietert et 
al., 1991b); Using myocytes from rat portal vein, it has been 
found that activation of adrenoceptors induces the 
formation of Ins (1,4,5)P3 and mobilizes calcium from 
intracellular stores (Lepretre et al., 1994); 3) WB 4101 (a 
selective adrenoceptor antagonist), 5-methyl-urapidil ( a 
selective adrenoceptor antagonist) and CEC (an 0^13-
adrenoceptor antagonist) all inhibited both phasic and tonic 
contraction induced by sympathetic nerve stimulation in the 
perfused rat tail artery (Sulpizio and Hieble, 1991); 4) 5-
methyl-urapidil (a selective antagonist) and CEC could not 
discriminate ai-adrenoceptor-mediated Ca^^ entry from the 
extracellular fluid and Ca^" release from intracellular stores 
(Schwietert et al., 1992) 
It was suggested that qJIA"adrenoceptors play a role in 
the tonic maintenance of arterial blood pressure and that ofie-
adrenoceptors participate in the response to exogenously 
administered agonists, since CEC treatment had no significant 
effect on resting systemic arterial blood pressure (Piascik et 
al., 1990). In support of this was the finding that CEC had 
only minor effects on a^-adrenoceptor-mediated increase in 
diastolic blood pressure in the pithed rat (Schwietert et al., 
1992) . 
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5. 5-Hydroxytryptamine Receptors in Vascular Smooth Muscle 
5.1. 5-Hydroxytryptamine Receptor Subtypes 
It is well knovm that the biogenic amine 5-
hydroxytryptamine (5-HT, serotonin) causes numerous 
physiological and pharmacological effects in various organs 
and tissues. Thus, it has been suggested for a long time that 
5-HT might act on multiple 5-HT receptors. The first 
pharmacological evidence for the existence of 5-HT receptor 
subtypes came from Gaddum and Picarelli in 1957. Their 
subdivision into M and D receptor subtypes was based on 
findings in the isolated guinea pig ileum where 5-HT induced 
contractions by two different mechanisms. In one instance, a 
direct contractile action on the smooth muscle by 5-HT was 
antagonized by phenoxybenzamine (Dibenzyline) and the sites 
which mediated this action were designated as D receptors. A 
second mechanism involved an indirect action via the release 
of acetylcholine and this was antagonized by Morphine. The 
sites responsible for this action were called M receptors 
(Gaddum and Picarelli, 1957). 
The development of radioligand binding and molecular 
biology techniques has brought a major breakthrough in 
receptor classification. Based on radioligand binding studies, 
Bradley et al. (1986) proposed that 5-HT receptors could be 
divided into three subtypes: 5-HTi, 5-HT2 and 5-HT3. Now it is 
apparent that 5-HT receptors can be classified into seven 
subtypes (Hoyer et al., 1994). They comprise the 5-HTi, 5-HT2 
and 5-HT3 subtypes, as well as the uncloned 5-HT4 receptor. The 
5-HTs, S-HTg and 5-HT7 receptor genes were recently cloned, but 
the receptors have yet to be fully characterized (Hoyer et 
al., 1994) . 
Based on transductional characteristics, it is clear 
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that receptors for 5-HT fall into two super families: a 
ligand-gated ion channel super-family (the 5-HT3 subtype) and 
a G-protein coupled super-family (the remaining families). 
The 5-HTi receptor family includes 5-HTib, S-HTm, 
5-HTie and 5-HTip receptors. The S-HTi^, B-HTm, S-HTm/ 5-HTIE and 
5-HTIF receptors have been cloned and shown to share a high 
degree of homology and to have intronless genes in the coding 
sequence region. They also share a common transduction system 
in being negatively coupled to adenylate cyclase, presumably 
via a common or similar G-protein link. 5-Hydroxytryptaminei 
receptors have a high affinity for 5-hydroxytryptamine and 5-
carboxamidotryptamine (5-CT) and mediate effects that are 
antagonized by methiothepin and methysergide, but not by 
antagonists at S-HTj (ketanserin, spiperone), 5-HT3 (MDL 72222, 
tropisetron) or 5-HT4 (GR 113808, SC 53606) receptors (Erode, 
1990; Hoyer et al., 1994). 
5-Hydroxytryptamine2A, B-HTJB and S-HTjc are members of 
the 5-HT2 receptor family. All three B-HTj receptors are G-
protein-linked and mediate their effects through activation of 
phospholipase C. In addition, all three subtypes have close 
homology. 5-Hydroxytryptaminea receptors have a low affinity 
for 5-HT. Activation of S-HTj receptors mediates effects that 
are susceptible to antagonism by ketanserin, but are resistant 
to antagonism by 5-HT3 receptor antagonists (MDL 72222, 
tropisetron) and 5-HT4 receptor antagonists (GR 113808, SC 
53606) (Erode, 1990; Hoyer et al., 1994). 
5-Hydroxytryptamine3 receptor activation triggers a 
rapid depolarization because of a transient inward current 
response contingent on the opening of cation selective 
channels (Peters et al., 1992). 5-HT3 receptors are 
characterized by their high affinity for cocaine derivatives 
(ICS 205-930 and MDL 72222) (Erode, 1990; Hoyer et al., 1994). 
5-Hydroxytryptamine4 receptors are positively linked to 
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adenylate cyclase (Dumis et al., 1988). GR ,113808 and SB 
204070 are the most potent and selective 5-HT4 receptor 
antagonist described to date (Ford and Clarke, 1993). 
5.2. 5-Hydroxytryptamine Receptors in Vascular Smooth Muscle 
The effects of 5-HT on vascular smooth muscle are 
complex. 5-Hydroxytryptamine can cause either vasoconstriction 
or vasodilation, depending on the conditions. This complexity 
is due to the fact that 5-HT can act on different cell types 
of one tissue (e.g. on smooth muscle or on endothelial cells 
of the blood vessel wall) or on different subtypes of 5-HT 
receptors (e.g., S-HT^, S-HTj or 5-HT4 receptors in vascular 
smooth muscle). To date, three families of 5-HT receptors (5-
HTi, 5-HT2 and 5-HT4 subtypes) have been functionally 
demonstrated to be involved in the vascular responses to 5-HT 
(Martin, 1994; Saxena and Villalon, 1990). 
S-HTj-like receptors are a group of receptors that have 
pharmacological characteristics that are similar to 5-HTi 
receptors, but which have not been positively equated with any 
of the 5-HTi-binding site subtypes. 5-HTi-like receptors appear 
to mediate a number of functional responses which include 
vasoconstriction and vasorelaxation. 
In the majority of blood vessels examined to date, 
vasoconstrictor 5-HTi-like receptors co-exist to varying 
degrees with 5-HT2 receptors (Docherty and Hyland, 1986; 
Maclennan and Martin, 1992; van Nueten et al., 1985). However, 
the distribution and functional importance of this 5-HT 
receptor type may well be underestimated. For example, in 
physiological Oj tension only 5-HT2 receptors were present in 
the human umbilical artery, whereas high O2 tension revealed a 
vasoconstrictor 5-HTi-like receptors (MacLennan et al., 1989). 
In dog saphenous vein, the vasoconstrictor 5-HTi-like 
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receptor, with a pharmacological similarity to B-HTm, appears 
to inhibit adenylate cyclase (Sumner and Humphrey, 1990). How 
this transduction pathway leading to vasoconstriction by 5-
HTi-like receptors needs more study. 
A number of reports have now described 5-HT relaxation 
of tonically constricted, isolated blood vessels in which 
endothelium was denuded (Feniuk et al., 1983; Martin et al., 
1987; Sumner et al., 1989). Available evidence indicates that 
the 5-HTi receptor mediating vasorelaxation is positively 
coupled to cAMP formation (Sumner et al., 1989; Trevethick et 
al., 1986). 
The 5-HTi-like receptors which mediate vasoconstriction 
display a close pharmacological similarity to the B-HTm 
subtypes (Kaumann et al., 1993). However, the 5-HTi-like 
receptors which mediate vasorelaxation display a resemblance 
to the 5-HT7 receptors (Bard et al., 1993). However, in both 
cases identity between the functional receptor and the . 
respective gene product remains to be established. 
Activation of 5-HTi-like receptors has been demonstrated 
to elicit vasorelaxation indirectly, by stimulating the 
release of an endothelium-derived relaxing factor (EDRF) 
(Bodelson et al., 1993; Glusa, 1992; Leff et al., 1987; Sumner 
and Humphrey, 1988). It has been claimed that endothelial 5-
HTi-like receptors are of the S-HTm subtype (Schoeffter and 
Hoyer, 1990) . 
5-Hydroxytryptamine2 receptors are widely distributed in 
peripheral tissues (Bradley et al., 1986). S-HTsa receptors 
mediate the powerful constrictor actions of 5-HT in a wide 
range of arteries and veins, especially conduit vessels 
(Apperley et al., 1976; Cohen et al., 1981; Feniuk et al., 
1983; Leff and Martin, 1986). In vascular smooth muscle, 
activation of S-HTj receptors results in the production of 
Ins(l,4,5)P3 and DAG (Cory et al., 1986; Roth et al., 1984; 
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1986). In addition, S-HTa receptors also mediate Ca^* influx in 
vascular smooth muscle (Zhang and Dyer, 1991c). 
The existence of 5-HT4 receptors in vascular smooth 
muscle was reported in sheep pulmonary vein by Cocks and 
Arnold (1992). These authors found that 5-HT potently relaxed 
this vessel when it was precontracted with endothelin-1. A 
similar result was observed in the same tissue by Zhang and 
Dyer (unpublished observation). Activation of 5-HT4 receptors 
in bovine pulmonary artery smooth muscle cells increased the 
accumulation of cAMP, which was mediated by Gs (Becker et al., 
1992) . 
In addition to its direct vasoconstriction, 5-HT also 
amplifies responses to other vasoconstrictors (Chang and 
Owman, 1989; de la Lande, 1992; Meehan et al., 1986; Szabo et 
al., 1991; van Nueten et al., 1982; Yang et al., 1992). The 
amplifying effects appear to be mediated via either 5-HTi-like 
receptors (Chang and Owman, 1989; de la Lande, 1992) or S-HTj 
receptors (Meehan et al., 1986; Szabo et al., 1991; van 
Nueten et al., 1982). 
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Abstract 
5-Hydroxytryptamine (5-HT) is a potent constrictor of 
the ovine umbilical artery and contracts the vessel via 
activation of 5-HT2 receptors. The present studies were 
designed to investigate whether 5-HT induces the hydrolysis 
of phosphoinositide in the ovine umbilical artery. Segments 
of the ovine umbilical artery were preincubated with 
[^H]inositol prior to determining the time-course and 
concentration-response relationship to 5-HT. Inositol 
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monophosphate (InsPi) , inositol bisphosphate (InsPa) and 
inositol trisphosphate (InsPj) were isolated by anion-
exchange chromatography and the radioactivity was counted. 
Generation of inositol phosphates in response to 5-HT was 
rapid (5-10 sec), although the increases in the accumulation 
were not significant. The accumulation quickly returned to 
unstimulated basal levels followed by secondary significant 
rises. 5-HT (10"®-lO"® M) in a concentration-dependent manner 
stimulated the hydrolysis of phosphoinositide during a 30 
min exposure to the agonist. The 5-HT-induced accumulation 
of inositol phosphates was inhibited by ketanserin, a 
selective S-HTj receptor antagonist, suggesting the 
involvement of 5-HT2 receptors. 
Phosphoinositide; 5-hydroxytryptamine; Umbilical artery 
1. Introduction 
It is well known that agonist-induced vasoconstriction 
is accompanied by activation of phospholipase C (Abdel-
Latif, 1986). The hydrolysis of phosphatidylinositol 4,5-
bisphosphate (PIP2) generates inositol 1,4,5-trisphosphate 
(Ins(1,4,5)P3 and diacylglycerol (DAG). Inositol 1,4,5-
trisphosphate has been shown to release Ca^"^ from 
intracellular stores in smooth muscle thereby initiating 
contraction (Somlyo et al., 1985; Suematsu et al., 1984). 
Activation of PKC may have a role in maintaining the 
sustained phase of contraction (Rasmussen et al., 1987). 
Increased formation of inositol phosphates induced 
by 5-hydroxytryptamine (5-HT) has been shown in various 
vascular smooth muscle (Berta et al., 1986; Doyle et al.. 
53 
1986; Nakaki et al., 1985). 5-Hydroxytryptamine2 receptor 
antagonists inhibit the 5-HT-induced increase in inositol 
phosphates suggesting that activation of S-HTa receptors are 
involved in phosphoinositide turnover (Cohen and Wittenauer, 
1987; Roth et al., 1986). 
S-hydroxytryptamine is a potent constrictor of 
umbilical artery (Dyer, 1970; Maclean et al., 1992). The 
contraction induced by 5-HT was found to be mediated by 5-
HTa receptors (Zhang and Dyer, 1990). In the present study 
we have investigated the effect of 5-HT on phosphoinositide 
hydrolysis in the ovine umbilical artery. 
2. Materials and Methods 
2.1. Materials 
Myo-[^H]inositol (16 Ci/mmol) was obtained from New 
England Nuclear (Boston, MA). Dowex AG 1X8 (formate form) 
and disposable columns (10 ml) were from Bio-Rad 
Laboratories (Richmond, CA). 5-Hydroxytryptamine creatinine 
was purchased from Sigma Chemical (St. Louis, MO). 
Ketanserin tartrate was from Janssen (Beerse, Belgium). 
2.2. Tissue preparation. 
Mixed breed sheep within 2 weeks of term (145 days) 
were euthanized with an i.v. injection of pentobarbital 
sodium. Umbilical cords were quickly removed and placed in 
an oxygenated modified Krebs' solution of the following 
composition (in mM): NaCl, 115.21; KCl, 4.70; CaClz, 1.80; 
MgS04, 1.16; KH2PO4, 1.18; NaHCOa, 22.14 and dextrose, 7.88. 
Disodium EDTA (0.03 mM) was added to suppress the oxidation 
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of amines. The arteries were carefully cleaned free from 
connective tissue and cut into 0.4-0.5 cm wide ring 
segments. 
2.3. Inositol Phosphates Determination, 
Production of inositol phosphates was measured by 
modification of the procedure previously described by Roth 
et al. (1986). Briefly, the segments were preincubated in 
Krebs' solution at 37 °C for 30 min under a 95% 02-5% CO2 
atmosphere and then transferred to vials containing 20 
/iCi/ml of myo- [^H] inositol. The incubation was continued for 
4 hrs. After washing 3 times with warm oxygenated Krebs' 
solution to remove free myo-[^H] inositol, LiCl (final 
concentration 10 mM) was then added to the incubation 
solution. Following 15 min of incubation, the following 
protocols were used : 1) lO"* M 5-HT was applied (for time-
course study) and the tissues were incubated for various 
times; 2) 5-HT was added at various concentrations for the 
concentration-response study; 3) ketanserin (lO"' M) was 
added 30 min before 10"* M 5-HT was applied. At the end of 
the incubation, the reaction was terminated by immersing the 
ring segments in liquid N2. The tissues were then 
transferred to 2 ml ice-cold methanol:chloroform:HC1 
(200:100:1) for approximately 3 min and then were rapidly 
blotted dry, weighed and homogenized in the same 
methanol:chloroform:HC1 mixture. Chloroform (1 ml) and water 
(1.1 ml) were added to the homogenate. After standing on ice 
for 4 hrs, the homogenate were centrifuged to separate the 
phases. The upper phase was then added to 1 ml of Dowex AG 
1X8 (formate form) resin packed in a disposable column (Bio-
Rad). The columns were then washed sequentially with 15 ml 
of water to elute free myo-[^H] inositol, 15 ml of 0.2 mM 
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ammonium formate-0.1 M formic acid to elute inositol 
monophosphate (InsPi) , 15 ml of 0.6 M ammonium formate-0.1 M 
formic acid to elute inositol bisphosphate (InsPj) and 
finally 15 ml of 1.0 M ammonium formate-0.1 M formic acid to 
elute inositol trisphosphate (InsPj) . One ml of each 
fraction was then transferred to liquid scintillation vials 
and 15 ml scintillation cocktail was added and radioactivity 
was determined by a liquid scintillation spectrophotometry. 
2,4. Statistics. 
Results are expressed as means ± S. E.; n, the number 
of observations refers to the animals used. Student's t test 
was used and a p value of <0.05 was taken as significant. 
3. Results 
3.1. Time-course of S-HT-stimulated formation of 
inositol phosphates 
The effect of duration of stimulation on the 
accumulation of individual inositol phosphates in response 
to 5-HT in the ovine umbilical artery was investigated. As 
shown in fig. 1, following stimulation with 10"* M 5-HT, 
there were small transient but not significant increases in 
the formation of InsP^ and InsPj (20.3% and 7.5%, 
respectively), then the accumulation of these two inositol 
phosphates declined towards unstimulated basal levels 
followed by a secondary increase after 5 min which were 
significantly higher than the unstimulated basal values at 
30 min (107% and 98% for InsPi and InsPj, respectively). The 
accumulation of InsPj was biphasic. 5-Hydroxytryptamine 
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stimulated a slow rise of accumulation of InsPj which 
reached a peak of approximately 35% at 60 to 90 sec. InsPa 
then declined towards unstimulated basal level at 2 min and 
then continued to rise during the 5-30 min period. 
3 . 2 .  C o n c e n t r a t i o n - r e s p o n s e  o f  5 -HT-stimulated 
formation of inositol phosphates 
Fig. 2 illustrates the concentration-response curve 
for 5-HT-induced formation of inositol phosphates in the 
ovine umbilical artery. Stimulation of the umbilical artery 
with 5-HT for 30 min increased the accumulation of InsP^ 
and InsPa at 5-HT concentrations of 10'®-2 X 10"^ M. The 
significant accumulation of InsPj was observed only at the 
concentrations of 10'®, 10"' M and 2 X lO"* M. 
3.3. Effect of Ketanserin on 5-HT-induced formation of 
inositol phosphates 
As shown in fig. 3, 10"* M 5-HT produces significant 
increases in the accumulation of InsP^, InsPz and InsPj. 
Pretreatment of tissues with ketanserin (lO'"' M) , a 5-HT2 
antagonist, significantly blocked the increase of inositol 
phosphates, indicating involvement of 5-HT2 receptors. 
4. Discussion 
The hydrolysis of phosphoinositide is an essential 
step in signal transducing mechanism for vasoconstrictyors. 
Extensive studies of 5-HT-induced phosphoinositide turnover 
in blood vessels have been made in aorta (Cohen and 
Fig. 1. Time-course for 5-HT-induced accumulation of 
inositol phosphates in the ovine umbilical arteiry. The basal 
accumulation at time 0 for InsP^, InsPj and InsPj were 
144.4±13.3, 89.0±11.7 and 22.5±6.8 cpm/mg wet tissue, 
respectively. Each point represents the mean+S.E. of 5-6 
animals. * Significantly different from corresponding basal 
accumulation, P<0.05. 
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Wittenauer, 1987; Nakaki et al., 1985; Roth et al., 1986) 
and smooth muscle cell lines derived from the aorta (Doyle 
et al., 1986; Pauwels et al., 1989). To our knowledge, there 
is no study of phosphoinositide hydrolysis conducted on the 
umbilical artery. 
5-Hydroxytryptamine contracts vascular smooth muscle 
via interaction with S-HTa and 5-HTi-like receptors (Saxena, 
1989), In the ovine umbilical artery, 5-HT produces 
vasoconstriction via B-HTj receptors (Zhang and Dyer, 
1990). Interaction with S-HTj receptors has been shown to 
increase phosphoinositide hydrolysis in vascular smooth 
muscle (Roth et al., 1986; Doyle et al., 1986; Cohen and 
Wittenauer, 1987) and there is a high correlation 
between 5-HT-induced contraction and phosphoinositide 
hydrolysis (Roth et al., 1986). Our results suggest that as 
in the aorta (Roth et al. 1986), 5-HT stimulates the 
hydrolysis of phosphoinositide via 5-HT2 receptors in the 
umbilical artery. 
The breakdown of PIP2 is a rapid process, which is 
usually observed within seconds (Rana and Hokin, 1990). 
Generally, time-course studies have showed that agonists 
increase the accumulation of InsPj by 10-20% within 15 sec 
(Abdel-Latif, 1986). Our data showed an increase of 17% of 
InsPj at 10 sec, although this increase was not significant. 
Our finding is consistent with the conclusion by Abdel-Latif 
(1986). There are two alternative routes for the metabolism 
of Ins(1,4,5)P3. In one pathway it is sequentially 
dephosphorylated to free inositol, whereas in the other 
pathway it is transformed into Ins(1,3,4,5)P4 before being 
dephosphorylated. The half-life of Ins(1,4,5)P3 is ~4 sec 
and Ins(l,3,4)P3 has a slower turnover than Ins(1,4,5)P3 
(Berridge, 1987; Rana and Hokin, 1990). In addition, lithium 
has been shown to selectively enhance accumulation of 
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Ins(1,3,4)Pj but not that of Ins(1,4,5)P3 (Rana and Hokin, 
1990). Therefore, the continuous increase in InsPj after 5-
10 sec in our study may reflect the accumulation of 
Ins(1,3,4)P3, since isoforms of InsPa could not be separated 
with the method used in our study. The accumulation of InsPj 
in response to 3 X 10"^ M was less than 10"® M 5-HT. A 
similar phenomenon was also observed by Labelle and Murray 
(1990) for norepinephrine-induced formation of InsPa in rat 
tail artery. Such an event could result from the rapid 
degradation of InsPj. The difficulty of measuring InsPj in 
vascular smooth muscle have been noted by some laboratories 
(Fox et al., 1985; McMillan et al., 1986). 
The accumulation of inositol phosphates in response to 
5-HT in the ovine umbilical artery are concentration-
dependent, which is similar to that found by Roth et al. 
(1986) in the rat aorta. Similarly, the accumulation of 
inositol phosphates was time-dependent, which is in 
agreement with the findings in cultured vascular smooth 
muscle cells (Leysen and Pauwels, 1990). 
In summary, we have demonstrated that 5-HT induced an 
increase in inositol phosphates in the ovine umbilical 
artery. The accumulation of inositol phosphates induced by 
5-HT is time-dependent and concentration-dependent and is 
mediated by S-HTj receptors. 
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Abstract 
The interaction between norepinephrine and 5-
hydroxytryptamine was investigated in ovine uterine artery. 
The contractions in response to 5-hydroxytryptamine (5 X 10" 
® M) were amplified by pretreatment with subthreshold (10"® 
M) and threshold (3 X 10"® M) concentrations of 
norepinephrine. The amplification by subthreshold 
concentration of norepinephrine of contractions induced by 
5-hydroxytryptamine was abolished by prazosin (10"® M), an 
tti-adrenoceptor antagonist, but not by yohimbine (lO"' M), an 
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"Ota-adrenoceptor antagonist. The amplifying effects were 
also markedly inhibited by nifedipine (10"® M), a L-type 
voltage-operated calcium channel blocker and by H-7 (10"^ 
M), the putative protein kinase C (PKC) inhibitor. Our 
results suggest that norepinephrine amplifies 5-
hydroxytryptamine-induced contractions of ovine uterine 
artery through oii-adrenoceptors, and an increase in Ca^"^ 
influx and activation of PKC. 
Uterine arteiry; 5-hydroxytryptamine; norepinephrine; 
amplification 
1. Introduction 
Both norepinephrine (NE) and 5-hydroxytryptamine (5-
HT) are potent vasoconstrictors of the uterine artery (Dyer 
and Gough, 1971; Ekstrom et al., 1991). The uterine artery 
is innervated by the sympathetic nervous system and NE is 
the principal neurotransmitter (Ekesbo et al., 1991). In 
response to NE, vasoconstriction occurs as a result of 
activation of ofi-adrenoceptors in the ovine uterine artery 
(Isla and Dyer, 1990). The plasma concentration of 5-HT is 
extremely low and almost all of the 5-HT in the blood is 
contained in the platelets. However, when the platelets 
aggregate, they will release 5-HT into the blood leading to 
a high local concentration. Platelets constitute the main 
source of 5-HT which is potentially available to vascular 
smooth muscle. 5-Hydroxytryptamine-imraunofluorescent nerves 
have been found in uterine vasculature (Amenta et al., 
1992), and it is suggested that these nerves are actually 
adrenergic nerves in which 5-HT is taken up and stored and 
that 5-HT could be released as a "false transmitter" 
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(Jackowski et al., 1989). Kawasaki and Takasaki (1984) 
suggested that 5-HT released from vascular adrenergic nerve 
endings may contribute to the maintenance of local vascular 
tone. The 5-HT-induced contraction of the ovine uterine 
artery is mediated by 5-HT2 receptors (Zhang and Dyer, 
1990). It is possible, in certain situations, that NE and 5-
HT may interact with each other on the uterine vasculature. 
In various species, 5-HT has been documented to 
enhance ofi-adrenoceptor-mediated vasoconstriction (van 
Nueten et al., 1981; Meehan et al., 1988; Luscher and 
Vanhoutte, 1988; Xiao and Rand, 1989). In addition, 5-HT 
also potentiated the contractile responses to acetylcholine 
(Asano and Hidaka, 1980), histamine (van Nueten et al., 
1982), angiotensin II (van Nueten et al., 1982), 
prostaglandin Fja, vasopressin (Xiao and Rand, 1989) , and 
endothelin (Yang et al., 1992). 
However, reports on the amplification by NE of 
vasoconstriction induced by other agonists are relatively 
few. Norepinephrine was found to amplify contractile 
responses to acetylcholine (Asano and Hidaka, 1980), 5-HT 
(Stupecky et al., 1986) and angiotensin II (Prins et al., 
1992). 
During pregnancy, blood flow through the uterine 
(caruncular) arteries is the main source to the fetus for 
oxygen and nutrients. Decreased uterine blood flow in 
response to vasoactive substances could compromise fetal-
maternal exchange. Therefore, interaction between NE and 5-
HT on the uterine vasculature during pregnancy may be of 
importance. 
The purpose of the present study was to investigate: 
1) whether NE amplifies the 5-HT-induced vasoconstriction on 
the isolated ovine uterine artery; and 2) the underlying 
mechanism(s) for the possible amplification. 
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2. Material and Methods 
2.1. Tissue Preparation 
Adult pregnant mixed breed sheep near term were 
euthanized with an i.v. injection of phentobarbital. Uterine 
arteries were carefully removed without stretching and 
placed in a modified Krebs solution of the following 
composition (mM): NaCl, 115.21; KCl, 4.70; CaClz, 1.80; 
MgSO^, 1.16; KH2PO4, 1.18; NaHCOa, 22.14; and dextrose, 7.88. 
EDTA (0.03 mM) was added to suppress oxidation of amines. 
Uterine arteries were cleaned of extraneous fat and 
connective tissue and cut into 3-4 mm rings. The rings were 
mounted between two stainless wires in 10 ml organ baths 
containing Krebs solution maintained at 37°C. The Krebs 
solution was aerated with 95% 02-5%C02. One wire was 
attached to a fixed support while the second wire was 
connected to Grass FT 0.3 transducers and contractions were 
recorded by a Grass polygraph tmodel 7). The arterial rings 
were equilibrated under 2 g tension over 60-90 min. The 
tissues were then exposed to 10"® M 5-HT for 10 min. 
Subsequently, the rings were washed with fresh Krebs 
solution twice and allowed to relax to base line. After 
equilibration for another 30 min, the experimental protocol 
began. 
2.2. Experimental Protocol 
The rings were repeatedly exposed to 5 X 10'® M 
5-HT until a reproducible response was obtained. The 
interval between each addition of 5-HT was 30 min. Then a 
subthreshold concentration of NE (10"® M) was added into the 
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bath for 5 min and followed by the addition of 5 X 10"® M 5-
HT. In some experiments, a threshold concentration of NE (3 
X 10'® M) was used followed by 5 X 10"® M 5-HT. 
In the experiments in which prazosin (10"® M) and 
yohimbine (10"' M) were used, they were added to the bath 
25 min before the addition of the subthreshold concentration 
of NE (10"® M) . 
Nifedipine (10'® M) and H-7 (10"® M) were preincubated 
with the tissues for 25 min before addition of subthreshold 
concentration of NE (10'® M) or vehicle. Nifedipine 
experiments were carried out in a darkened room. 
2.3. Drugs 
The following drugs were used: NE bitartrate, 5-HT 
creatinine sulfate, 1-(5-isoquinolinesulphonyl)-2-
metylpiperazine (H-7) (Sigma Chemical Co., St. Louis, MO), 
prazosin HCl (Pfizer Inc., Brooklyn, NY), yohimbine HCl 
(Merck, Rahway, NJ), and nifedipine HCl (Ciba 
Pharmaceuticals, Summit, NJ). 
2.4. Statistics 
Results are expressed as mean ± S. E., n, referred to 
the number of animals used. Student's t test was used for 
statistic analysis and P<0.05 was taken as significant. 
Results 
In the isolated ovine uterine artery, both 
subthreshold and threshold concentrations of NE 
significantly potentiated 5-HT (5 X 10"® M)-induced 
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vasoconstriction (Fig. 1). Pretreatment with subthreshold 
concentrations of NE (10"® M) resulted a. 2.1 fold 
increase in the contractile response initiated by 5-
HT (5 X 10"® M). Moreover, a threshold concentration of NE 
(3 X 10"® M) , which by itself evoked only a small increase 
in tension, amplified almost 4.5 fold the 5-HT-induced 
contraction. The response to the threshold concentration of 
norepinephrine was subtracted from the combined response. 
The a-adrenoceptor antagonists, prazosin and yohimbine 
were used to investigate the subtype of a-adrenoceptor 
involved in the potentiating effect. Amplification of 5-HT 
by a subthreshold concentration NE (10"® M) in the ovine 
uterine artery was completely blocked by the oii-adrenoceptor 
antagonist, prazosin (10"® M) (Fig. 2), suggesting the 
involvement of q!i - adrenoceptors. The aj-adrenoceptor 
antagonist, yohimbine (lO"') had no effect on the 
amplification response (Fig. 3), indicating no role for 0I2 
adrenoceptors in the potentiation of 5-HT-induced 
contraction by subthreshold concentration of NE. Neither 
prazosin (10"® M) nor yohimbine (10"' M) significantly altered 
responses to 5-HT (5 X 10"® M) in the ovine uterine artery 
(data not shown). 
Nifedipine (10'® M) , a calcium entry blocker, 
significantly attenuated (68.1%) the response to 5-HT (5 X 
10"® M) in the ovine uterine artery (fig. 4) . In the 
presence of nifedipine, a subthreshold concentration of NE 
had no potentiating effect on the 5-HT-induced 
vasoconstriction. 
The protein kinase C (PKC) inhibitor, H-7 (10"® M), 
markedly decreased (45.6%) the 5-HT-induced contractile 
response in the ovine uterine artery. The amplification of 
5-HT-induced vasoconstriction by a subthreshold 
concentration NE was also blocked by H-7 (fig 5). 
Fig. 1. Effect of norepinephrine on contraction induced by 
5-hydroxytryptatnine (5-HT, 5 X 10'® M) on isolated rings of 
ovine uterine artery, NEjg,; subthreshold concentration of 
norepinephrine (NE(s), 1 X 10'® M) ; NEj^): threshold 
concentration of norepinephrine (NEj^j, 3 X 10"® M) . The force 
produced by threshold concentration of norepinephrine was 
subtracted from the combined force. The values are mean ± 
S.E. of 5-7 animals. * indicates that values are 
signficantly different form the control response to 5-
hydroxytryptamine (P<0.05). 
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Fig. 2. Effect of prazosin (Praz, 10'® M) on contractions 
induced by 5-hydroxytryptamine (5-HT, 5 X 10"® M) in the 
presence of a subthreshold concentration of norepinephrine 
(NE(s,, 10'® M) on ringss of ovine uterine artery. The values 
are mean ± S. E. of 5 animals. * Indicates that values are 
significantly different from the control response to 5-
hydroxytryptamine, P < 0,05. ** Indicates that values are 
significantly different from the response to 5-
hydroxytryptamine in the presence of NE(s) (P < 0.05) . 
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Fig, 3. Effect of yohimbine (Yoh, 10"'' M) on contraction 
induced by .5-hydroxytryptamine (5-HT, 5 X 10'® M) in the 
presence of a subthreshold concentration of norepinephrine 
(NE(s)_ 10"® M) in rings of ovine uterine artery. The values 
are mean ± S. E. of 6 animals. * indicates that values are 
significantly different from the control response to 5-
hydroxytryptamine (P < 0.05). 
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Fig. 4. Effect of nifedipine (Nif, 10"® M) on contractions induced by 5-
hydroxytryptamine {5-HT, 5 X 10"® M) in the presence or absence of a subthreshold 
concentration of norepinephrine (NE,s), 10"® M) in rings of ovine uterine artery. 
The values are mean ± S. E. of 5-7 animals. * indicates that the values are 
significantly different from the control response to 5-hydroxytryptamine, P < 0.05. 
** indicates that values are significantly different from the response to 5-
hydroxytryptamine in the presence of NE(s) (P < 0.05) . 
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Fig. 5. Effect of H-7 (10"^ M) on contractions induced by 5-hydroxytryptamine {5-HT, 
5 X 10"® M) in the presence or absence of a subthreshold concentration of 
norepinephrine (NE,s), 10"® M) in rings of ovine uterine artery. The values are mean 
+ S. E. of 5-7 animals. * indicates that values are significantly from the control 
response to 5-hyddroxytryptamine, P < 0.05. ** indicates that values are 
significantly form the response to 5-hydroxytryptamine in the presence of NEjg, (P 
< 0.05). 
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Conrnient 
In the physiological environment, vascular smooth 
muscle is exposed to a variety of agonists. Hence the 
response of vascular smooth muscle to an agonist may be 
modified by the presence of other agonists. The present 
study demonstrated that both subthreshold and threshold 
concentrations of NE amplified 5-HT-induced contraction of 
ovine uterine artery. 
The amplification of 5-HT-induced vasoconstriction by 
a subthreshold concentration of NE requires the activation 
of tti" but not Qfa-adrenoceptors, since the amplification 
response was completely blocked by prazosin, a selective a^-
adrenoceptor antagonist, but not by yohimbine, a selective 
a2-adrenoceptor antagonist. These findings are consistent 
with previous work from this laboratory which found that 
only but not ofj-adrenoceptors mediated contraction of 
the 'ovine uterine artery (Isla and Dyer, 1990). 
Three potential events have been suggested for 
agonist-induced contraction of smooth muscle: 1) Ins 
(1,3,5)P3 induced Ca^"" release from the sarcoplasmic 
reticulum; 2) influx of extracellular Ca^""; and 3) 
modulation of the Ca^*-sensitivity of the contractile 
regulatory apparatus (Somlyo et al., 1991). Any of these 
three events could be influenced by the presence of either 
antagonists or other agonists. 
The contractile response to 5-HT of the uterine artery 
was significantly attenuated by H-7, a putative PKC 
inhibitor. This observation is compatible with the findings 
that PKC is present in the ovine uterine artery (Magness et 
al, 1992) and that phorbol 12,13-dibutyrate contracted the 
uterine arteries of the guinea pig and sheep (Fallgren et 
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al., 1989; Hu and Dyer, 1994). The present finding that the 
contraction to 5-HT was markedly inhibited by nifedipine, a 
calcium channel blocker, is compatible with observations 
previously reported from our laboratory (Isla and Dyer, 
1990; Zhang and Dyer, 1991). 
In the presence of nifedipine or H-7, the 
amplification of 5-HT-induced contraction by NE was 
significantly attenuated or completely blocked, indicating 
the involvement of both voltage-operated calcium channels 
(VOCs) and PKC. Activation of either a^-adrenoceptors or 5-
HTa receptors will increase Ca^* influx (Cauvin et al., 1982 
Chiu et al., 1986; Zhang and Dyer, 1991) and stimulate 
phosphoinositide hydrolysis (Chiu et al., 1987; Roth et al. 
1986) in vascular smooth muscle. These observations suggest 
that activation of oii-adrenoceptors and 5-HTj-receptors act 
on the same signalling pathways to produce contraction. 
Subthreshold concentrations of NE might increase the 
sensitivity of the VOCs to 5-HT and hence increase the 
availability of Ca^" to the contractile apparatus. There are 
at least two potential processes by which subthreshold 
concentrations of NE might amplify 5-HT-induced contraction 
1) partially depolarize the plasma membrane of the vascular 
smooth muscle, and 2) increase the opening probability of 
VOCs (Bean, 1989; Nelson, 1990). Either of these two 
processes would enhance the coupling between VOCs and 5-HT 
receptors and the availability of Ca^* to the contractile 
apparatus and thereby amplify the contractions induced by 5 
HT. Our results are similar to findings in rabbit femoral 
artery in which the amplification of angiotensin Il-induced 
vasoconstriction by NE was blocked by nifedipine (Prins et 
al., 1992), although a threshold concentration of NE was 
used in their experiment. Furthermore, Bay K8644, a Ca^* 
channel activator, at concentrations which did not elicit a 
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contraction, potentiated NE-induced contraction in the 
rabbit basilar artery (Laher et al., 1989). 
Subthreshold concentrations of NE could also enhance 
the 5-HT-stimulated activity of PKC. As indicated earlier, 
both adrenoceptors and 5-HT2 receptors are coupled to the 
phosphoinositide cascade. It is possible that G-protein 
coupled phospholipase C could be partially activated by NE 
at subthreshold concentration and consequently potentiate 5-
HT stimulated formation of Ins(1,4,5)P3 and diacylglycerol. 
It has been reported that angiotensin II and endothelin-1 
potentiate NE-induced contraction by activating PKC in the 
rabbit facial artery and aorta (Henrion et al., 1992a; 
Henrion and Laher, 1993). In addition, the activation of PKC 
by phorbol ester also amplifies phenylephrine-induced 
vasoconstriction in the guinea pig aorta (Molderings and 
Schumann, 1989) . 
ofi-Adrenoceptor agonists, such as NE and 
phenylephrine, have been shovm to increase the calcium 
sensitivity of the contractile apparatus in vascular smooth 
muscle (Kitazawa et al., 1989; Nishimura et al., 1990). The 
increase in the Ca^'' sensitivity of the contractile 
apparatus is mediated via a G protein and secondary to an 
increase in myosin light chain phosphorylation and 
inhibition of myosin light chain phosphatase (Kitazawa et 
al., 1989). The amplification response could be due to the 
activation of PKC (Drenth et al., 1989; Nishimura et al., 
1990; Ruzycky and Morgan, 1989), since phorbol esters mimic 
the amplifying effects. Supporting the amplification effect 
may be an inhibition of myosin light chain phosphatase 
activity, since phorbol 12,13-dibutyrate inhibited myosin 
light chain phosphatase activity in the rat aorta (Itoh et 
al. , 1993) . 
In the rabbit femoral artery, amplification by 
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angiotensin II of NE-induced contraction was accompanied by 
an increased Ca^^ influx (Purdy and Weber, 1988). However, 
Henrion et al. (1992a, 1992b) found only PKC but not Ca^* 
was involved in the amplification by angiotensin II of NE-
induced contractions in the rabbit facial artery and aorta. 
Our results indicated that both Ca.^* influx and activation 
of PKC participated in the amplifying effect by NE of 5-HT-
induced contraction of the ovine uterine artery. While our 
study can not be directly compared to the two above reports, 
it is possible that the amplification response may vary with 
species and/or vascular beds. 
In summary, we have demonstrated that NE amplifies 5-
HT-induced contraction of ovine uterine artery via 
activation of oii-adrenoceptors. The amplification involves 
participation of both VOCs and PKC. 
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Abstract 
The subtypes of ai-adrenoceptors in the ovine uterine 
artery and umbilical vein were investigated. The 
irreversible ceiQ-adrenoceptor antagonist, 
chlorethylclonidine (CEC) (5 X 10'® M) inhibited 
norepinephrine-induced contraction in the ovine uterine 
artery without depressing the maximal response. 
Chlorethylconidine significantly reduced the maximal 
response in the ovine umbilical vein. The calcium channel 
blocker, nifedipine (10"® M), inhibited norepinephrine-
95 
induced contractions on both blood vessels. The competitive 
Qfift-adrenoceptor antagonist, WB4101, inhibited the 
norepinephrine-induced contractile response in ovine uterine 
artery and umbilical vein with pAa values of 8.30 and 8.45, 
respectively. Combined use of CEC with either WB 4101 or 
nifedipine produced an additive inhibition of 
norepinephrine-induced contractions on both blood vessels. 
Prazosin, WB 4101 and CEC all inhibited norepinephrine-
induced contraction due to release of calcium from 
intracellular stores. Our results suggest there is 
heterogeneity of aj-adrenoceptors in the ovine uterine 
artery and umbilical vein and that adrenoceptors may 
also be involved in the release of intracellular stored 
calcium. 
cXi-Adrenoceptors; subtypes; uterine artery; umbilical vein 
1. Introduction 
Qfi-Adrenoceptors are not homogeneous and have been 
subclassified into two subtypes: otiA and Q!ib based on both 
binding and functional studies (Bylund et al., 1994; 
Minneman, 1988) . WB4101 and chlorethylclonidine (CEC) have 
frequently been used as pharmacological tools to assist in 
the subclassification of tti-adrenoceptors. Those receptors 
which are CEC-insensitive and have a high affinity for 
WB4101 are designated as adrenoceptors, while those 
which are CEC-sensitive and have a low affinity for WB4101 
are classified as q!IB - adrenoceptors. Molecular cloning has 
confirmed the existence of three subtypes of Q!I-
adrenoceptors (Catecchia et al., 1988; Lomasney et al.. 
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1991; Perez et al., 1991; Schwinn et al. , 1990). QfiA/D» 
and Subtypes are all expressed in vascular smooth muscle 
(Lomasney et al., 1991; Piascik et al., 1994; Ping and 
Faber, 1993; Price, 1994). 
Blood flow in the uterine artery and umbilical vein 
are crucial for the growth of the fetus. The uterine artery 
transports blood rich in O2 and nutrients to the placenta 
where O2 and nutrients are taken up by the fetal blood and 
CO2 is discharged into the maternal circulation. The 
umbilical vein transports the oxygenated blood from the 
placenta to the fetus. Although the uterine artery is 
innervated by adrenergic nerve fibers, degeneration occurs 
during pregnancy (Bell and Malcolm, 1978; Sigger et al., 
1986). On the other hand, umbilical vessels are not 
innervated (Fox and Khong, 1990; Spivack, 1943). Hence, the 
uterine artery during pregnancy and the umbilical vein are 
somewhat similar in that they are under little or no 
influence from the sympathetic nervous system. However, in 
response to tXi-adrenoceptor agonists, both vessels contract 
via activation of ofi-adrenoceptors (Isla and Dyer, 1990; 
Zhang and Dyer, 1991). 
The objective of the present study was to investigate 
and characterize the subtypes of cxi-adrenoceptors in the 
ovine uterine artery and umbilical vein. 
2. Materials and Methods 
2.1. Tissue Preparation. 
Adult pregnant mixed breed sheep near term were 
euthanized with an injection of pentobarbital sodium. 
Uterine arteries and umbilical cord were carefully removed 
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without stretching and placed in a modified Krebs' solution 
of the following composition (mM): NaCl, 115; KCl, 4.70; 
CaClz, 1.80; MgS04, 1.16; KH2PO4, 1.18; NaHCOa, 22.14; and 
dextrose, 7.88. EDTA (0.03 mM) was added to suppress 
oxidation of amines. The uterine artery and umbilical vein 
were cleaned of connective tissues and cut into 3-4 mm ring 
segments. The ring segments were mounted between two wires 
in 10 ml organ baths containing Krebs' solution maintained 
at 37°C. The Krebs' solution was aerated with a mixture of 
95% 02-5% COj. One wire was attached to a fixed support 
while the second wire was connected to Grass FT 0.3 
transducers and contractions were recorded by a Grass 
polygraph (model 7) or a Beckman polygraph (model R611). The 
segments were equilibrated under 2 g tension over 60-90 min 
with regular replacement of the bath fluid at 20 min 
intervals. The ring segments were then primed with 10'^  M 
norepinephrine. After complete washout of the agonist, 
desimipramine (10"' M) , corticosterone acetate (10'® M) and 
propranolol (10"® M) were included in the Krebs' solution to 
block neuronal uptake^ , extraneuronal uptakes and jS-
adrenoceptors, respectively. These agents were in contact 
with the tissues for 30 min before a protocol began and 
throughout the protocol. Concentration-response curves were 
generated by cumulative addition of the agonist in 
approximately one-half log increments, and the response to 
each concentration of agonist was allowed to stabilize 
before the next addition. 
2.2. Determination of pAz values for WB 4101. 
Control concentration-response relationship for 
norepinephrine were constructed in the absence of WB 4101. 
Following complete washout of the norepinephrine and return 
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to baseline, one of three concentrations (10"®, 3 X 10'® and 
lO"' M) of WB 4101 were added to the organ baths and allowed 
to equilibrate with the tissues for 3 0 min before obtaining 
a second concentration-response relationship to the agonist 
in the presence of the antagonist. PAj (=-log KB) values 
were determined as described by Arunlakshana and Schild 
(1959) , ECgo values for the agonist in the absence (ECgo) and 
presence of the antagonist (EC50') were used to calculate 
the concentration ratio (CR) (CR = ECgo'/ECso) and a plot of 
log (CR-1) against -log [antagonist] was made to obtain the 
pAz value (X -intercept) and slope of the regression line. 
2.3. Effects of CEC on norepinephrine-induced 
contractions. 
For studies in which the irreversible qIIB-
adrenoceptor-alkylating agent, CEC, was used, a control 
concentration-response relationship was first constructed 
for norepinephrine. After complete washout and return to 
baseline, the tissues were then exposed to CEC (5 X 10'® M) 
for 3 0 min, followed by complete washout of the antagonist 
for 60 min at 15 min intervals. Subsequently, a second 
concentration-response relationship was obtained for 
norepinephrine. 
2.4. Effects of nifedipine on norepinephrine-induced 
contractions. 
For studies in which the calcium channel blocker, 
nifedipine was used, tissues were incubated with nifedipine 
(10'® M) for 3 0 min in a darkened room following complete 
washout of the agonist after obtaining the first 
concentration-response relationship. After incubation with 
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nifedipine, a second concentration-response relationship was 
obtained. 
2.5. Effects of combined use of CEC with prazosin, WB 
4101 or nifedipine 
In this protocol, a control concentration-response 
relationship to norepinephrine was obtained, followed by 
washout of the agonist from the bath. Subsequently, tissues 
were exposed to CEC (5 X 10"® M, 30 min) , followed by 
washout of the antagonist for 60 min at 15 min-interval. The 
tissues were then incubated in the presence or absence of 
prazosin (10"® M) , WB 4101 (10'® M) or nifedipine (10'® M) for 
30 min before obtaining a second concentration-response 
relationship. The dissociation constants (Kg) for prazosin 
and WB 4101 were calculated using the equation (Furchgott, 
1972): KB = [B]/(CR-1), where [B] is the concentration of 
the antagonist, and CR is the concentration ratio described 
in section 2.2.. Nifedipine studies were conducted in a 
darkened room. 
2.6. Correction for changes in tissue sensitivity 
In all the above studies, one tissue was run in 
parallel with the experimental tissues, but received no 
antagonists and was used to correct for time-dependent 
changes in agonist sensitivity during the course of the 
experiment (Furchgott, 1972). 
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2.7. Effects of Oil-adrenoceptor antagonists on 
contractions to norepinephrine in the absence of external 
calcium 
Tissue were challenged with norepinephrine (10"® M) 
repeatedly in normal Krebs' solution (1.8 mM Ca^'^) until a 
reproducible response was obtained. The interval between 
each addition of norepinephrine was 45 min. After complete 
washout of the agonist and equilibration in normal Krebs' 
solution for 60 min, the Krebs' solution was replaced with a 
Ca^^-free Krebs' solution containing EGTA (1 mM). The 
tissues were washed with Ca^'^-free Krebs' solution 3 times 
for a period of 10 min. a^-Antagonists (prazosin, 10"® M or 
WB 4101 10"® M) were then added to the bath for 20 min. The 
tissues were then exposed to norepinephrine (10"® M). In a 
separate tissue, after complete washout of norepinephrine 
(10"® M) in normal Krebs' solution, the tissues were 
incubated with CEC (5 X 10"® M) for 30 min. The tissue was 
then washed over 30 min with normal Krebs' solution to 
remove CEC. The tissue was then washed with Ca^^-free Krebs' 
solution containing EGTA (1 mM) 3 times and then incubated 
in the Ca^^-free Krebs' solution continued for another 20 
min. The tissue was then exposed to norepinephrine (10"® M). 
The contractile response to norepinephrine for each tissue 
in the normal Krebs' solution was taken as 100%. 
2.8. Drugs. 
(-)Norepinephrine bitartrate, desimipramine 
hydrochloride, propranolol hydrochloride and corticosterone 
acetate were purchased from Sigma Chemical Co. (St. Louis, 
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MO). WB4101 and CEC were obtained form Research Biochemical 
Inc. (Natick, MA). Nifedipine and prazosin hydrochloride 
were gifts from Ciba Pharmaceuticals (Summit, NJ) and Pfizer 
Inc. (Brooklyn, NY), respectively. 
2.9. Statistics. 
Results are given as mean ± S.E.. Differences between 
means were tested for significance using the Student's t-
test for paired or unpaired data. A P values of less than 
0.05 was taken as significant. 
3. Results 
3.1. Norepinephrine sensitivity pDz (- logECgo) of the 
uterine artery and umbilical vein 
Norepinephrine produced concentration-dependent 
contractions of both the ovine uterine artery and umbilical 
vein (fig. 1). The pDa values for norepinephrine were 6.54 ± 
0.08 and 6.31 ± 0.07 in the uterine artery and umbilical 
vein, respectively. There was no difference between the 
uterine artery and umbilical vein (Table 1). 
3.2. Effects of CEC on norepinephrine contractions 
Chloroethylclonidine (5 X 10'® M), the selective, 
irreversible (XIB-adrenoceptor antagonist, displaced the 
concentration-response curve for norepinephrine in the 
uterine artery to the right but did not reduce the maximal 
response (fig. 2A, table 2). However, in the umbilical 
Fig. 1. Contractile responses induced by norepinephrine in 
the ovine uterine artery and umbilical vein. Each points 
represents mean ± S.E. of 5-7 animals. 
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Table 1 
pDj values and maximal contractions for norepinephrine in the 
uterine artery and umbilical vein. Mean ± S.E. 
pDz Maximal Contraction 
(g) 
Uterine Artery 6.5 ± 0.1 31.7 ± 3.3 
(5) (5) 
Umbilical Vein 6.3 ± 0.1 11.8 ± 1.7® 
(7) (7) 
® P<0.05, comparing to uterine artery. 
Fig. 2. Concentration-response curves for norepinephrine in 
the absence and presence of CEC (5 X 10'^ M, 30 min) in the 
ovine uterine artery and umbilical vein. Each point 
represents mean ± S.E. of 5-7 animals. 
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Table 2 
Effects of CEC on norepinephrine-induced vasoconstriction in the 
uterine artery and umbilical vein. Mean ± S.E. 
Uterine Artery Umbilical Vein 
pDz 
Maximal 
Contraction 
(g) 
pDa 
Maximal 
Contraction 
(g) 
Control 6.6±0.1 30.5±3.6 6.3±0.1 13.8±2.7 
(5) (5) (7) (7) 
CEC 5.8±0.1® 30.6±3.6 4.8±0.1® 8.8±1.7^ 
(5) (5) (7) (7) 
® P<0.05, comparing to control 
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vein, CEC pretreatment significantly depressed the maximal 
contraction (63.8% of control) and shifted the 
concentration-response curve to the right (fig. 2B, table 
2) . Chloroethylclonidine did not contract either the uterine 
artery or umbilical vein. 
3.3. Effects of nifedipine on norepinephrine 
contractions 
Blockade of calcium channels by nifedipine (10"® M) in 
the uterine artery shifted the concentration-response curve 
to norepinephrine to the right without significantly 
decreasing the maximal response (fig 3A). In the umbilical 
vein, nifedipine displaced the concentration-reponse curve 
to norepinephrine to the right and significantly depressed 
the maximal contraction to norepinephrine (fig. 3B, table 
3) . 
3.4. Competitive antagonism by WB4101 
In the uterine artery, the selective ofjA-adrenoceptor 
antagonist, WB4101 (10"®, 3 X 10"® and 10"' M) , shifted the 
concentration-response curves for norepinephrine to the 
right in both the uterine artery and umbilical vein (fig. 
4) . A Schild plot for WB4101 against norepinephrine yield a 
straight line with a slope of unity for both vessels (-1.08 
for both the uterine artery and umbilical vein) (fig. 5). 
The pAj values for WB4101 against norepinephrine were 8.30 
and 8.46 in the uterine artery and umbilical vein, 
respectively. 
Fig. 3. Concentration-response curves for norepinephrine in 
the absence and presence of nifedipine (10'® M, 3 0 min) in 
the ovine uterine artery and umbilical vein. Each point 
represents mean + S.E. of 5-7 animals. 
110 
Pi 
o 
-(-> 
o 
a 
u 
-•-> 
o 
o 
cd 
a 
• FH 
X 
oJ 
^••'1 
o 
+J 
a 
O' 
o 
120 
100 
80 
60 
40 
20 
A. Uterine Artery 
o Control 
-a 
• Nifedipine 1 X 10 M 
o 
9^ /I-
/ -r 
•t 
0 L 
t_ 
•-
-JL-
• •—8— • -
- 1 0  -9 - 8  -7 - 6  -5 -4 
120 
100 
80 
60 
40 
20 
0 
B. Umbilical Vein 
o Control 
• Nifedipine 1 X 10 M 
/•f-f 
,9 A 
/ ? 
•8—•— 
- 1 0  -8 -7 -6 -5 
Log [Norepinephrine] (M) 
-4 
-3 
Ill 
Table 3 
Effects of nifedipine on norepinephrine-induced vasoconstriction in 
the uterine artery and umbilical vein. Mean ± S.E. 
Uterine Artery Umbilical Vein 
PD2 
Maximal 
Contraction 
(g) 
pDa 
Maximal 
Contraction 
(g) 
Control 6.5±0.1 28.0±2.0 6.4±0.1 12.8±2.9 
(5) (5) (7) (7) 
Nifedipine 5.7±0.1= 26.0±1.5 5.4±0.1^ 9.7±2.4^ 
(5) (5) (7) (7) 
^ P<0.05, comparing to control 
Fig. 4. Concentration-response curves for norepinephrine in 
the absence and presence of WB 4101 (10"® - 10'"' M, 30 min) 
in the ovine uterine artery and umbilical vein. Each point 
represents mean ± S.E. of 5-7 animals. 
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Fig. 5. A Schild plot for the antagonism between WB 4101 and 
norepinephrine in the ovine uterine artery and umbilical 
vein. Each point represents the average of 5-7 animals, r: 
correlation coefficient. 
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3.5. Effects of combining CEC with prazosin, WB 4101 
or nifedipine 
Similar to the studies reported in section 3.2., CEC 
shifted the concentration-response curve for norepinephrine 
to the right in both the uterine artery and umbilical vein. 
However, the maximal responses to norepinephrine was 
depressed in the umbilical vein but not in the uterine 
artery. 
Prazosin (10'® M) alone displaced the concentration-
response curve for norepinephrine to the right in both ovine 
uterine artery and umbilical vein. The -log KQ values for 
prazosin against norepinephrine were 8.8 and 9.4 in the 
uterine artery and umbilical vein, respectively. 
Pretreatment with CEC (5 X 10'® M) followed by prazosin 
further shifted the concentration-response curve for 
norepinephrine to the right in both vessels (fig. 6). The -
log KB values for prazosin did essentially not change after 
CEC pretreatment, i.e. 8.8 and 9.4 in the uterine artery and 
umbilical vein, respectively (table 4). 
WB 4101 at the concentration of 10'® M shifted the 
concentration-response curve for norepinephrine to the right 
in both the uterine artery and umbilical vein, which is 
similar to the data reported in section 3.4.. Pretreatment 
of the tissues with CEC (5 X 10'® M) followed by WB 4101 
further shifted the concentration-response curve to 
norepinephrine to the right in both the uterine artery and 
umbilical vein (fig. 7). The -log Kg values were 8.2 and 8.5 
in the ovine uterine arteiy and umbilical vein, respectively 
(table 4), which are almost the same as those obtained using 
the Schild plot method. After pretreatment with CEC, the -
log KB values were almost the same as those before CEC 
treatment, i.e. 8.2 and 8.6 in the ovine uterine artery and 
Fig, 6. Effects of prazosin (10'® M) alone or with CEC 
(5 X 10'® M, 30 min) pretreatment on norepinephrine-induced 
contractions of the ovine uterine artery and umbilical vein. 
Each point represents mean ± S,E. of 5 animals. 
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Table 4 . Efffects of CEC pretreatment on antagoinst affinity of 
ofi-adrenoceptors in the uterine artery and umbilical vein. n=5-6. 
- Log KB 
Antagonist ' 
Uterine Artery Umbilical Vein 
Before CEC After CEC Before CEC After CEC 
Prazosin 8.8 8.8 9.4 9.4 
WB 4101 8.2 8.2 8.5 8.6 
Fig. 7, Effects of WB 4101 (10"® M) alone or with CEC 
(5 X 10'® M, 30 min) pretreatment on norepinephrine-induced 
contractions of the ovine uterine artery and umbilical vein. 
Each point represents mean ± S.E. of 6 animals. 
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umbilical vein, respectively (table 4). The inhibition was 
additive for the combined use of CEC and WB 4101. 
Nifedipine (10'® M), a L-type calcium channel blocker 
which was suggested to be selective for the a^ j^ -
adrenoceptors, caused a rightward shift of the 
concentration-response curve for norepinephrine in both the 
uterine artery and umbilical vein. The pDz values for 
norepinephrine in the presence of nifedipine were 5.7 ± 0.1 
and 5.5 ± 0.1 for the uterine artery and umbilical vein, 
respectively, which were almost the same as those reports in 
section 3.3. After pretreatment with CEC, nifedipine further 
shifted the concentration-response curves to norepinephrine 
to the right in both the uterine artery and umbilical vein 
(fig. 8) . The pDj values for norepinephrine in the presence 
of nifedipine after CEC pretreatment were 4.9 ± 0.1 and 4.2 
± 0.2 for the uterine artery and umbilical vein, 
respectively, which are significantly different form those 
without CEC pretreatment (p < 0.05). The inhibition of 
responses to norepinephrine by CEC and nifedipine was 
additive in both the uterine artery and umbilical vein. 
3.6. Effects of 0!^-antagonists on contractions to 
norepinephrine in the absence of external calcium 
In normal Krebs' solution, norepinephrine (10"^ M) 
produced a contraction in both the uterine artery and 
umbilical vein which was composed of two components: a 
phasic contraction followed by a tonic contraction. In Ca^^-
free Krebs' solution, norepinephrine (10'® M) produced a 
transient contraction in both blood vessels. The 
contractions in response to norepinephrine (10"® M) in Ca^^-
free medium were 39.7 ± 3.0 % and 18.1 ± 3.2 % in the 
uterine artery and umbilical vein, respectively, of that in 
Fig. 8, Effects of nifedipine (10"® M) alone or CEC (5 X 10"® 
M, 3 0 min) pretreatment on norepinephrine-induced 
contractions of the ovine uterine artery and umbilical vein. 
Each point represents mean ± S.E. of 6 animals. 
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Fig. 9. Effects of adrenoceptor antagonists (prazosin 
CPraz), WB 4101 and CEC) on contractions induced by 
norepinephrine (NE) in the absence of external calcium in 
the ovine uterine artery and umbilical vein. The values are 
mean + S.E. of 5-9 animals. * Indicates that values are 
significantly different form control values in the absence 
of external calcium, P < 0.05. 
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normal Krebs' solution (fig. 9) . Prazosin (10"® M) , a 
selective q!I-adrenoceptor antagonist, WB 4101 (10"® M) , a 
selective antagonist, and CEC (5 X 10"® M) , an 
irreversible q!ib antagonist, all significantly inhibited 
norepinephrine (10"® M) contractions in both the uterine 
artery and umbilical vein in the absence of external 
calcium. The magnitude of the inhibition was similar for all 
three antagonists in the uterine artery. However, in the 
umbilical vein, prazosin and CEC were more potent in 
inhibiting contractions to norepinephrine. 
4. Discussion 
Vasoconstriction elicited by alpha-adrenoceptor 
agonists in the ovine uterine artery and umbilical vein were 
shown to be mediated via by adrenoceptors (Isla and Dyer, 
1990; Zhang and Dyer, 1991). Using pharmacological tools we 
have investigated the possible heterogeneity of 
adrenoceptors in these two vessels. 
Prazosin, a selective oti-adrenoceptor antagonist, 
competitively inhibited contractile responses induced by 
norepinephrine in both the uterine artery and umbilical 
vein, the Kq values for prazosin were similar to those 
observations in previous studies from our laboratory (Isla 
and Dyer, 1990; Zhang and Dyer, 1991). These observations 
suggested the presence of cxi-adrenoceptors in both tissues. 
Chlorethylclonidine (CEC) is an irreversible 
alkylating derivative of clonidine and possesses different 
effectiveness in blocking cvi-adrenoceptors in rat tissues 
(Han et al., 1987a; Johonson and Minneman, 1987). It was 
proposed that those q!I-adrenoceptors which are sensitive to 
CEC alkylation are of the subtype, while those 
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adrenoceptors which are insensitive to CEC alkylation are of 
the ofift-subtype (Minneman, 1988) . In the present study, CEC 
shifted the concentration-response curves for norepinephrine 
to the right in both the uterine artery and umbilical vein. 
In the uterine artery, CEC shifted the concentration-
response curve for norepinephrine to the right without 
depressing the maximal contraction. Similar observations 
have been made in other vascular smooth muscle (Aboud et 
al., 1993; Oriowo et al., 1992; Oriowo and Ruffolo, 1992; 
Tian et al., 1990). It is not clear why CEC depresses the 
maximal response in some vessels but not in others. It is 
unlikely that receptor reserve has a role in this 
phenomenon, since previous studies showed that there was no 
substantial oti-adrenoceptor reserve in the uterine artery 
(Isla and Dyer, 1990). During pregnancy, the contractility 
of the uterine artery in response to norepinephrine 
increased in sheep (Annibale et al., 1989) and guinea pig 
(Fallgren et al., 1988). However, there was no change in the 
amount of oii-adrenoceptors in pig uterine arte2:Y during 
pregnancy (Guenther et al., 1988). It may be possible that 
norepinephrine has high receptor coupling efficacy in the 
uterine artery during pregnancy. Bevan et al. (1989) 
proposed that the affinity of receptor for either agonists 
or antagonist could be modified by the environment of the 
receptor. The uterine artery is under extensive influence of 
sex hormones during pregnancy. It is possible that the 
microenvironment and the structure of qJIB"adrenoceptors, as 
well as intracellular signaling pathways coupled to oii-
adrenoceptors in the uterine artery have been modified 
during pregnancy. Our results may also imply that even 
without the participation of adrenoceptors, activation 
of CKift-adrenoceptors alone by norepinephrine could still 
produce the maximal contractile response in the uterine 
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artery. However, activation of both and oi^^-
adrenoceptors is required to obtain the maximal contractile 
response in the umbilical vein. Recently, it has been 
reported that otiD-adrenoceptor is expressed in vascular 
smooth muscle (Piascik et al., 1994) and that this subtype 
is partially inactivated by CEC (Perez et al., 1991) . It is 
possible that both cXib" and cXID-adrenoceptor may be present 
in the uterine artery. Our results suggest that there is 
heterogeneity of q!I-adrenoceptors in both the uterine artery 
and umbilical vein. 
Radioligand binding and functional studies using a 
competitive adrenoceptor antagonist, WB4101, 
demonstrated two separate population of adrenoceptors in 
rat brain tissues (Han et al., 1987a, 1987b; Morrow and 
Creese, 1986) . The oIia subtype is designated as having high 
affinity for WB4101 and (XIQ subtype with low affinity for 
WB4101. In the present study, WB4101 shifted the 
concentration-response curve for norepinephrine to the right 
in a parallel manner. The Schild plot yielded a straight 
line whose slope was not significantly different from unity 
in both the uterine artery and umbilical vein, suggesting 
competitive antagonism (Kenakin, 1982). The pAz values for 
WB4101 in the uterine artery and umbilical vein were 8.30 
and 8.45, respectively, which are comparable to those values 
(8.07-9.49) reported in other blood vessels (Aboud et al., 
1993; Han et al., 1990a; Muramatsu et al., 1990; Oriowo and 
Ruffalo, 1992; Takayanagi et al., 1991). These results 
indicate the existence of cXIA-adrenoceptors in both the 
uterine artery and umbilical vein. 
In the presence of nifedipine, a L-type calcium 
channel blocker, the concentration-response curves to 
norepinephrine were shifted to the right in both the uterine 
artery and umbilical vein. ai^-Adrenoceptor-mediated 
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contraction is thought to be coupled to dihydropyridine-
sensitive calcium channels (Minneman, 1988). Our results 
suggest a possibility that Ca^'^ influx is involved in cXia" 
adrenoceptor-mediated contractions in both blood vessels. 
The findings of contractile responses to 
norepinephrine after CEC pretreatment in both the uterine 
artery and umbilical vein further suggests the possibility 
of adrenoceptor heterogeneity in both blood vessels. 
After pretreatment with CEC, contractions to norepinephrine 
were further inhibited by prazosin in both the uterine 
artery and umbilical vein. This indicates that the response 
which is resistant to CEC inactivation is still sensitive to 
antagonism by prazosin. Furthermore, we found that CEC-
resistant contractions to norepinephrine were also sensitive 
to antagonism by WB 4101 and nifedipine. The potencies of 
prazosin and WB 4101 were essentially unchanged following 
CEC pretreatment. These findings further suggest that 
contractions to norepinephrine which are CEC-resistant are 
mediated by adrenoceptor and that Ca^^ influx 
participates in ai^-adrenoceptor-mediated contractile 
responses in both the uterine artery and umbilical vein, and 
provides addition evidence that both and 
adrenoceptors co-exist in both the uterine artery and 
umbilical vein. Our results differ from studies reported by 
others in which neither prazosin nor WB 4101 antagonized the 
residual contractile responses to norepinephrine in the rat 
and dog aorta after pretreatment with CEC (Oriowo and Bevan, 
1990; Oriowo and Ruffolo, 1992). Oriowo and Bevan (1990) 
suggested that the CEC-resistant contraction to 
norepinephrine was mediated by a non-adrenoceptor. This is 
not the case in the uterine artery and umbilical vein, since 
combined use of CEC with prazosin or WB 4101 produced an 
additive inhibition of contractile responses to 
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norepinephrine. In addition, Oriowo and Ruffolo (1992) 
observed that CEC-resistant contractions to norepinephrine 
were sensitive to antagonism by prazosin and WB 4101 in 
rabbit aorta. These observations suggest that the ability of 
prazosin or WB 4101 to antagonize CEC-resistant contractions 
to norepinephrine is tissue-dependent. 
As proposed by Minneman (1988) , adrenoceptor-
mediated responses are associated with calcium influx from 
extracellular fluid and are sensitive to antagonism by 
WB4101 and nifedipine. aig-Adrenoceptor-mediated responses 
are thought to be linked to phospholipase C and mobilization 
of intracellular calcium and are sensitive to alkylation by 
CEC. Contractions induced by agonists in Ca^'^-free medium 
are thought to be the result of release of intracellular 
stored calcium by Ins(l,4,5)P3 (Bohr, 1988). Inhibition of 
contractions to norepinephrine by CEC in Ca^^-free medium in 
both the uterine artery and umbilical vein confirmed the 
suggestion that the cXiB-adrenoceptor is coupled to the 
release of intracellular calcium (Han et al., 1987b; 
Minneman, 1988). However, inhibition of contractions to 
norepinephrine by a low concentration of WB 4101 in Ca^*-
free medium in both vessels may suggest that the cXia-
adrenoceptor is also capable of releasing intracellular 
calcium. This finding is comparable with observations by 
Lepretre et al. (1994). These investigators demonstrated 
that activation of adrenoceptors stimulates 
phosphoinositide hydrolysis and mobilizes intracellular 
calcium in the rat portal vein. 
Both the and ajB-adrenoceptor subtype may not be 
coupled to only a single transduction pathway. In fact, 
besides the coupling mechanisms of a^- and cXig-adrenoceptors 
originally proposed by Minneman (1988) , cXuv-adrenoceptor 
subtype has recently been found to stimulate the hydrolysis 
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of phosphoinositide (Han et al., 1990b; Michel et al., 
1993) , while ceig-adrenoceptor subtype are reported to 
stimulate Ca^'^ influx (Han et al., 1992) . 
Based on their observations, Yamaguchi and Kopin 
(1980) proposed that the ofi-adrenoceptors are located at the 
neuroeffector junctions (junctional receptors) , while cxz" 
adrenoceptors are located at extrajunctional sites 
(extrajunctional receptors). This proposal was extended by 
Langer and Shepperson (1982a,b) , who suggested that oii-
adrenoceptors are located in the vicinity of uptake^ sites. 
Piascik and coworkers (1990a, b) further suggested that q!IA-
adrenoceptors are located junctionally while 
adrenoceptors are located extrajunctionally. Since the 
umbilical vessels are not innervated (Fox and Khong, 1990; 
Spivack, 1943), the previous finding (Zhang and Dyer, 1991) 
and present observations in the umbilical vein suggest the 
possibility of an extra junctional location for both and 
-adrenoceptors. It is generally accepted that the 
physiological role of postjunctional ai-adrenoceptors 
appears to be responsible for maintaining resting vascular 
tone, while extrajunctional aj"adrenoceptors may respond to 
circulating epinephrine (Langer and Shepperson, 1982b; 
Ruffolo, 1991). Recently, Piascik et al., (1990a, b) 
proposed that cKIA-adrenoceptors appear to play a role in the 
maintenance of vascular tone, while ttiQ-adrenoceptors 
respond to circulating catecholamines. Our findings suggest 
that both and aiQ.adrenoceptors in the umbilical vein 
could respond to circulating catecholamines and participate 
in the regulation of resting tone, since there are no 
apparent cxj-adrenoceptors in the umbilical vein (Zhang and 
Dyer, 1991). 
In summary, our study found evidence for the 
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heterogeneity of oii-adrenoceptors in both the ovine uterine 
artery and umbilical vein. In addition, our findings also 
suggest that the adrenoceptor may be linked to the 
release of intracellular calcium. 
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Abstract 
The role of protein kinase C (PKC) in vasoconstriction 
of the ovine uterine artery was investigated using the 
putative PKC inhibitor, staurosporine. Norepinephrine, 
endothelin-1, KCl and phorbol 12,13-dibutyrate (PDBu) all 
produced concentration-dependent contractions. Endothelin 
was a more potent vasoconstrictor than norepinephrine in the 
141 
ovine uterine artery. PDBu induced-contractions were 
inhibited by staurosporine in a concentration-dependent 
manner, and were almost completely blocked by 10"' M 
staurosporine. Staurosporine had no inhibitory effect on 
contractions induced by KCl, suggesting that staurosporine 
is a relative specific PKC inhibitor in the ovine uterine 
artery. The contractile response induced by norepinephrine 
and endothelin-1 were inhibited by staurosporine, however, 
the inhibition was incomplete. These results suggest that 
activation of PKC is involved in agonist-induced 
contractions of the ovine uterine artery and that mechanisms 
other than PKC may contribute to the contraction process. 
Key words: protein kinase C, phorbol 12,13-dibutyrate, 
norepinephrine, endothelin-1, uterine artery 
1. Introduction 
Activation of protein kinase C (PKC) results in 
diverse biological responses (Nishizuka, 1984). 
Diacylglycerol (DAG) is the physiological activator of PKC 
in cells. At present, there are two known sources of 
formation of DAG: 1) hydrolysis of phosphoinositide by 
phospholipase C; and 2) hydrolysis of phosphatidylcholine by 
phospholipase C and D (Billah and Anthes, 1990; Exton, 
1990). Hydrolysis of phosphoinositide contributes to the 
early transient accumulation of DAG and the hydrolysis of 
phosphatidylcholine results in the late sustained 
accumulation of DAG (Nishizuka, 1992). Both norepinephrine 
and endothelin have been shown to induce the hydrolysis of 
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phosphoinositide (Labelle and Murray, 1990; Resink, 1990) 
and phosphatidylcholine (Gu et al., 1992; Liu et al., 1992) 
in vascular smooth muscle.The activating effect of DAG on 
PKC could be mimicked by tumor-promoting phorbol ester 
(Castagna et al., 1982). Activation of PKC by phorbol esters 
induced a slowly developing and sustained vasoconstriction 
(Forder et al., 1985; Gleason and Flaim, 1986; Khalil and 
van Breemen, 1988), suggesting that PKC may play a role in 
vasoconstriction (Rasmussen et al., 1987). 
The uterine artery during pregnancy transports blood 
to placenta to supply the fetus with oxygen and nutrients. 
Both norepinephrine and endothelin are potent 
vasoconstrictors of the uterine artery (Dyer and Guogh, 
1970; Edstrom et al., 1991). It has been reported that PKC 
activities in the sheep (Magness et al., 1991) and pig 
(Farley and Ford, 1992) uterine arteries decreased during 
pregnancy. However, the role of PKC in agonist-induced 
contractions of the uterine artery has been rarely studied. 
In the present study we have used staurosporine , a 
putative PKC inhibitor to examine the possibility that 
activation of PKC contributes to contractions induced by 
norepinephrine, endothelin-1, KCl or phorbol 12,13-
dibutyrate (PDBu). 
2. Materials and Methods 
2.1. Tissue Preparation 
Adult pregnant mixed breed sheep near term were 
euthanized with an injection of pentobarbital. Uterine 
arteries were carefully removed without stretching and 
placed in a modified Krebs' solution of the following 
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composition (mM) : NaCl, 115; KCl, 4,70; Calz/ 1.80; MgS04, 
1.16; KH2PO4, 1.18; NaHCOj, 22.14; dextrose, 7.88 and EDTA, 
0.03. The uterine artery was cleaned free of connective 
tissue and cut into 3-4 mm ring segments. The ring segments 
were mounted between two wires in 10 ml organ baths 
containing Krebs' solution maintained at 37°C. The Krebs' 
solution was aerated with a mixture of 95% 02-5% CO2. One 
wire was attached to a fixed support while the second wire 
was connected to Grass FT 0.3 transducers and contractions 
were recorded by a Grass polygraph (model 7). The segments 
were equilibrated under 2g tension over 60-90 min with 
regular replacement of Krebs' solution at 20 min intervals. 
Subsequently, all tissues were exposed to 90 mM KCl. All 
subsequent contractile responses in each ring segment were 
expressed as a percentage of the contractile response to KCl 
in that vessel. 
2.2. E f f e c t s  o f  s t a u r o s p o r i n e  o n  c o n t r a c t i o n s  i n d u c e d  b y  
norepinephrine and KCl 
Two sequential concentration-response curves were 
generated by the cumulative addition of the contractile 
agent (norepinephrine or KCl). Staurosporine (10'®-10''' M) 
was equilibrated with the tissues for 30 min before 
obtaining the second concentration-response relationship to 
norepinephrine or KCl. In all studies with norepinephrine 
and KCl, one ring segment received no staurosporine and was 
run in parallel with the experimental tissues. This tissue 
was used to correct for time-dependent changes in agonist 
sensitivity (time control). Response to norepinephrine was 
obtained in the presence of desimipramine (lO"' M), 
corticosterone acetate (10'® M) and propranolol (10"® M) to 
block neuronal uptake^, extraneuronal uptake2 and (3-
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adrenoceptors, respectively. Response to KCl was obtained in 
the presence of phentolamine (10"' M) in order to block the 
effects of any neurally released norepinephrine. These 
agents were in contact with tissues for 3 0 min before a 
protocol began and throughout the protocol. 
2.3. E f f e c t s  o f  s t a u r o s p a r i n e  o n  c o n t r a c t i o n s  i n d u c e d  b y  
endothelin-1 and phorbol 12,13-dibutyrate (PDBu) 
Concentration-response curves to endothelin-1 and PDBu 
were generated in the presence or absence of staurosporine 
(lO'^-lO"' M) on paired preparations. Staurosporine was added 
to the baths 30 min before obtaining a concentration-
response relationship to endothelin-1 and PDBu. 
2.3. Drugs 
(-) Norepinephrine hydrochloride, phorbol 12,13-
dibutyrate, endothelin-1, staurosporine and bovine serum 
albumin were purchased from Sigma Chemical Co. (St. Louis, 
MO). Norepinephrine was dissolved in saline (0.9% NaCl) and 
endothelin-1 was dissolved in saline containing 0.5% bovine 
serum albumin in order to prevent nonspecific binding to 
glassware (Kasuya et al., 1989). Initial stock solutions of 
PDBu and staurosporine were in dimethylsulfoxide (DMSO) and 
subsequent dilutions were made with saline. The final 
concentration of DMSO in the bath medium was less than 0.1% 
and had no effect on the contractility of the ovine uterine 
artery to KCl. 
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2.4. S t a t i s t i c s  
The results are expressed as mean ± S.E.. The data 
were analyzed by Student's t-test. A P value less than 0.05 
was taken as significant. 
3. Results 
3.1. Comparison of contractions induced by norepinephrine, 
KCl, endothelin-1 and PDBu 
In the isolated ovine uterine artery, norepinephrine 
induced a rapid contraction, whereas endothelin-1 and PDBu 
produced slow contractions. Norepinephrine, endothelin-1 and 
PDBu all caused concentration-dependent contractions in the 
ovine uterine artery (fig. 1). The pDj (-log ECgo) values are 
6.66 ± 0.16, 7.45 ± 0.13 and 5.33 ± 0.19 (n = 5-6) for 
norepinephrine, endothelin-1 and PDBu, respectively. The 
potencies of these agents were in the order of endothelin-1 
> norepinephrine > PDBu and were significantly different 
from each other (P < 0.05). 
3.2. E f f e c t  o f  s t a u r o s p o r i n e  o n  c o n t r a c t i o n  i n d u c e d  b y  K C l  
KCl induced concentration-dependent contractions in 
the ovine uterine artery. KCl-induced contractions were not 
affected by any concentration of staurosporine tested (10'®, 
3 X 10'® and lO"' M) (fig 2) . 
Fig. 1. Contractile responses induced by norepinephrine, 
endothelin-1 and phorbol 12,13-dibutyrate in the isolated 
ovine uterine artery. Each point represents mean ± S.E. of 
5-6 animals. 
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contraction induced by KCl in the ovine uterine artery. Each 
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3.3. E f f e c t s  o f  s t a u r o s p o r i n e  o n  c o n t r a c t i o n  i n d u c e d  b y  P D B u  
Staurosporine inhibited PDBu-induced contraction in a 
concentration-dependent manner in the ovine uterine artery 
(fig. 3). At the concentration of lO"' M, staurosporine 
inhibited the contraction to PDBu (10'® M) by 80.2 ± 5.2%. 
3.4. E f f e c t  o f  s t a u r o s p o r i n e  o n  c o n t r a c t i o n  i n d u c e d  b y  
norepinephrine 
The concentration-response curves for norepinephrine 
in the ovine uterine artery were shifted to the right by 
staurosporine (10'®-10"'' M) (fig. 4) . Staurosporine at 10'® M 
had no apparent effect on the norepinephrine (10"® M)-
induced contraction, whereas higher concentrations of 
staurosporine (3 X 10"® and lO"' M) significantly depressed 
the contractile responses to norepinephrine (10"® M) (22.2 
± 4.6% and 26.9 ± 5.0%, respectively). 
3.5. E f f e c t  o f  s t a u r o s p o r i n e  o n  c o n t r a c t i o n  i n d u c e d  b y  
endothelin-1 
Similarly, staurosporine also inhibited contractions 
induced by endothelin-1 in a concentration-dependent manner 
in the ovine uterine artery (fig. 5). The contractile 
responses to endothelin-1 (10"' M) was significantly 
attenuated by 3 X 10"® M and lO"' M staurosporine (28.1 ± 
3.3% and 37.8 ± 4.9%, respectively). 
Fig. 3. Effects of staurosporine (10"® - 10'' M) on 
contraction induced by phorbol 12,13-dibutyrate (PDBu) in 
the isolated ovine uterine artery. Each point represents 
mean ± S.E. of 5-6 animals. 
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4. Discussion 
Receptor-mediated vasoconstriction is accompanied with 
an increased formation of Ins (1,4,5) P3 and DAG from 
phosphatidylinositol 4,5-bisphosphate hydrolysis (Abedel-
Latif, 1986) . In addition, the breakdown of 
phosphatidylcholine also contributes to the accumulation of 
DAG in vascular smooth muscle (Billah and Anthes, 1990; 
Exton, 1990/Nishizuka, 1992). It is widely accepted that 
release of calcium from intracellular stores by Ins(1,4,5)P3 
is implicated in receptor-mediated vasoconstriction. 
However, there is not a general agreement on the role of PKC 
in vasoconstriction. While some investigators claimed that 
calcium is the determinant factor in vasoconstriction 
(Rembold and Murphy, 1988), other investigators argued that 
PKC is responsible for maintaining contraction (Rasmussen, 
1987). 
KCl contracts vascular smooth muscle via 
depolarization of the membrane which in turn stimulates Ca^^ 
influx through voltage-operated calcium channels (Bolton, 
1979). There is no involvement of PKC in KCl-induced 
contraction of smooth muscle (Haller et al., 1990). 
Staurosporine is a microbial product with an inhibitory 
effect on protein kinase C by inhibiting the catalytic 
domain (Tamoki and Nakano, 1990). The specificity of the 
action of staurosporine was examined with KCl. The failure 
of staurosporine to inhibit KCl-induced contraction suggest 
that staurosporine is not a nonspecific PKC inhibitor in 
the ovine uterine artery. In the rat aorta, staurosporine 
inhibited KCl-induced contraction and was suggested to be a 
nonselective PKC inhibitor (Shimamoto et al., 1993). Riiegg 
and Burgess (1989) suggested that staurosporine act on 
myosin light chain kinase instead of protein kinase C and 
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thereby prevent vasoconstriction. However, our results do 
not support this suggestion, since KCl-induced contraction 
of vascular smooth muscle is solely dependent on myosin 
light chain kinase. The discrepancy could result from tissue 
selectivity to staurosporine. 
PDBu, the widely used phorbol ester in studying PKC, 
produced a slow developing and sustained contraction in the 
ovine uterine artery. Similar results have been reported in 
the guinea pig uterine artery (Fallgren et al., 1989) as 
well as in other vascular beds (Chatterjee and Tejada, 1986; 
Forder et al., 1985; Gleason and Flaim, 1986). In the 
present study, we found that staurosporine at 10"' M, which 
had no inhibitory effect on KCl-induced contraction in the 
ovine uterine artery, produced an almost complete inhibition 
of PDBu-induced contraction. PKC is the PDBu receptor 
protein (Kikkawa et al., 1983). Furthermore, Magness et al. 
(1992) reported the presence of protein kinase C in the 
ovine uterine artery. Taking these observations together, we 
concluded that PDBu-induced contractions are mediated by 
activation of PKC in the ovine uterine artery. In another 
study, we found that PDBu-induced contractions of the 
uterine artery were attenuated by 10'® M nifedipine (Hu and 
Dyer, unpublished data). This phenomenon indicates that Ca^^ 
influx is involved in contraction induced by PDBu in the 
ovine uterine artery, which could result from modulation of 
voltage-operated calcium channels by PKC (Fish et al., 
1988) . 
Norepinephrine contracts ovine uterine artery through 
activation of cxi-adrenoceptors (Isla and Dyer, 1990) . 
Recently, two subtypes of tti-adrenoceptors, and q!ib/ have 
been pharmacologically identified in this vessel (Hu and 
Dyer, 1994). The hydrolysis of phosphoinositide mediated by 
cXiA" and cKIB"adrenoceptors (Han et al. , 1987; Lepretre et 
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al., 1994) and the hydrolysis of phosphatidylcholine 
mediated by oii-adrenoceptors (Gu et al., 1992) has been 
observed in vascular smooth muscle. These could constitute 
the sources of DAG for activation of protein kinase C. The 
inhibition of norepinephrine-induced contraction by 
staurosporine indicates that activation of PKC plays a role 
in norepinephrine-induced vasoconstriction of the ovine 
uterine artery. The inhibition of norepinephrine-induced 
contractions by staurosphrine has been demonstrated in other 
vascular smooth muscle (Abebe and MacLeod, 1990; Merkel et 
al., 1991). However, the partial inhibition of 
norepinephrine-induced contractions by 10'' M staurosporine, 
which almost abolished the contraction induced by PDBu, 
suggests that other mechanism besides PKC contribute to the 
norepinephrine-induced contractile responses. Khalil and van 
Breemen (1988) suggested Ca^^ influx is more important than 
activation of protein kinase C in phenylephrine-induced 
contractions. We also found that norepinephrine-induced 
contraction of the ovine uterine artery was inhibited by 
nifedipine, a blocker of voltage-operated calcium channel 
(Hu and Dyer, 1994). In addition, the Ca^*-sensitivity of 
the contractile apparatus may be increased by norepinephrine 
(Nishimura et al., 1990). 
Endothelin-1 is a potent vasoconstrictor (Yanagisawa 
et al., 1988). An in vivo study revealed that endothelin-1 
was more potent than norepinephrine or phenylephrine as a 
vasoconstrictor of the ovine uterine artery (Yang and Clark, 
1992). Our present in vitro observation confirmed the in 
vivo finding. The mechanisms for endothelin-induced 
contraction are not yet clear. Like norepinephrine, 
endothelin-1 also stimulates the hydrolysis of 
phosphoinositide and phosphatidylcholine to produce 
Ins(1,4,5)P3 and DAG in vascular smooth muscle (Liu et al.. 
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1992; Harden et al., 1989; Resnik et al., 1988). The 
activity of protein kinase C was increased by endothelin in 
vascular smooth muscle (Griendling et al., 1989; Haller et 
al., 1990; Lee et al., 1989). It has been suggested that the 
activation of PKC may contribute to endothelin-1-induced 
contractions (Ohlstein et al., 1989; Danthuluri and Brock, 
1990) . Data from our studies confirme the involvement of PKC 
in endothelin-1-induced contraction of the ovine uterine 
artery. However, the partial inhibition of endothelin-1-
induced contraction by 10"'' M staurosporine, which almost 
completely inhibited the response to PDBu, suggest that 
mechanisms other than PKC may also be involved. Goto et al. 
(1989) reported the activation of voltage-operated calcium 
channels by endothelin in vascular smooth muscle. 
Endothelin-1 was also found to increase the Ca^^'-sensitivity 
of the contractile apparatus in vascular smooth muscle 
(Nishimura et al., 1992). These mechanisms could have a role 
in endothelin-1-induced contraction of the ovine uterine 
artery. 
Although there is a dramatic decrease in PKC 
activities in the ovine uterine artery in late pregnancy 
(Magness; 1991), our studies demonstrated that PKC still 
plays a role in agonist-induced contractions of the ovine 
uterine artery. 
In summary, our studies indicate that staurosporine is 
a specific PKC inhibitor in the ovine uterine artery since 
it inhibited contractions to PDBu but not KCl. The 
inhibition of contractions to norepinephrine and endothelin-
1 suggest the involvement of PKC in the contractions to 
these agents. However, other mechanisms may also contribute 
to contractions induced by norepinephrine and endothelin-1. 
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GENERAL SUMMARY 
Uteroplacental blood flow is one of the most important 
rate-limiting factors for normal fetal growth and 
development. Uterine and umbilical vessels are under 
extensive influence of many factors, which could have an 
impact on fetal well-being. The vasoconstrictor effects of 
catecholamines (Dyer, 1970, Ekstrom et al., 1991; Fallgren 
and Edvisson, 1986; Isla and Dyer, 1990; Mak et al., 1984; 
Somlyo et al., 1965; Stjernquest and Owman, 1990; Tuncer et 
al., 1985; Zhang and Dyer, 1990a, 1991) and 5-HT (MacLean et 
al., 1989; Ribeiro et al., 1991; Somlyo et al., 1965; 
Templeton et al., 1991; Zhang and Dyer, 1990b, 1990c) have 
been documented in the uterine artery and umbilical 
vessels. The receptor subtypes mediated contractions induced 
by catecholamines and 5-HT in sheep are (Xi-adrenoceptors in 
the uterine artery as well as umbilical vein (Isla and Dyer, 
1990; Zhang and Dyer, 1991) and 5-HT2 receptors in the 
uterine and umbilical arteries (Zhang and Dyer, 1990a, 
1990b) , receptively. The oti-adrenergic and serotonergic 
mechanisms have been further investigated in the present 
studies. 
Receptor-mediated vasoconstriction is accompanied by 
phosphoinositide hydrolysis (Abdel-Latif, 1986). It has been 
reported that there is a good correlation between these two 
events (Gu et al., 1991; Rapoport, 1987; Roth et al., 1986). 
In the ovine umbilical artery, we demonstrated that 5-HT 
induces phosphoinositide hydrolysis via 5-HT2 receptors, 
which is time- and concnetration-dependent. Our findings may 
imply that receptor-mediated hydrolysis of phosphoinositide 
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could be involved in contractions induced by 5-
hydroxytryptamine in the ovine umbilical artery. 
Usually, there exist several agonists in the vicinity 
of the vascular smooth muscle. It is possible for these 
agonists to interact with each other. The amplification of 
one agonist-induced contraction by the other agonist has 
been reported in various vascular beds (Luscher and 
Vanhoutte, 1988; Prins et al., 1992; van Nueten et al., 
1981; Xiao et al., 1989; Yang et al., 1992). We observed 
that subthreshold concentration of NE via tti-adrenoceptors 
amplifies contractions induced by 5-HT in the ovine uterine 
artery. Ca^* influx through L-type VOCs and activation of 
PKC are involved in the amplifying effects. 
In the middle 1980s, it was found that q!i-
adrenoceptors were not homoglous (Minneman, 1988). Previous 
studies from our laboratory have shown the existence of cx-^ -
adrenoceptors in both the ovine uterine artery and umbilical 
vein (Isla and Dyer, 1990, Zhang and Dyer, 1991). We further 
characterized the subtypes of oii-adrenoceptor using 
pharmacological tools and found the heterogeneity of 
adrenoceptors in both blood vessels. In addition, we also 
observed that adrenoceptor might release intracellular 
Ca^*, which disagrees with the signaling mechanism for 
adrenoceptor suggested by Minneman (1988) . 
Receptor-mediated hydrolysis of phosphoinositide 
generates two second messengers: Ins(1,4,5)P3 and DAG 
(Berridge, 1987). Inositol 1,4,5-trisphosphate releases Ca^* 
from intracellular stores (Streb et al., 1983), while DAG 
activates PKC (Nishizuka, 1984). Activation of PKC has been 
suggested to play a role in agonist-induced contractions 
170 
(Rasmussen, 1987). Using the putative PKC inhibitor, 
staurosporine, we demonstrated that activation of PKC is 
involved in contractions induced by NE and endothelin-1 in 
ovine uterine artery, however, other mechanisms may also 
participate. Staurosporine is a relative selective PKC 
inhibitor in the ovine uterine artery, since the KCl-induced 
contractile response was not affected by staurosporine. 
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